,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,377,1,3,,10321615,14985,Inconclusive,42741659.0,5243.0,,,MDR-1,Other,,
1,875,1,2,,26754431,14985,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
2,880,2,1,,26754431,14985,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
3,880,2,1,,26754431,14985,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
4,880,2,1,,29215204,14985,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
5,880,2,1,,29215204,14985,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
6,881,2,2,,26754431,14985,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
7,881,2,2,,29215204,14985,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
8,884,1,2,,26754431,14985,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
9,885,1,2,,26754431,14985,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
10,887,1,2,,26754431,14985,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
11,889,1,3,,26754431,14985,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
12,892,1,2,,26754431,14985,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
13,893,1,2,,26754431,14985,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
14,893,1,2,,26754431,14985,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
15,894,2,1,,26754431,14985,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
16,894,2,1,,29215204,14985,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
17,900,1,3,,26754431,14985,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
18,901,1,2,,26754431,14985,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
19,902,1,2,,26754431,14985,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
20,923,1,2,,26754431,14985,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
21,924,1,2,,26754431,14985,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
22,995,1,2,,26754431,14985,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
23,1030,2,1,,26754431,14985,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
24,1030,2,1,,29215204,14985,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
25,1332,1,1,,49698474,14985,Inactive,,,,,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
26,1376,1,2,,47193687,14985,Inactive,15608158.0,886069.0,,IC50,Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU),Confirmatory,,
27,1379,1,2,,26754431,14985,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
28,1379,1,2,,29215204,14985,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
29,1385,2,2,,47193687,14985,Inactive,49168602.0,5888.0,,,Homologous recombination - Rad 51,Screening,,
30,1422,1,1,,47193687,14985,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
31,1452,1,1,,26754431,14985,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
32,1452,1,1,,29215204,14985,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
33,1454,1,1,,26754431,14985,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
34,1457,1,1,,26754431,14985,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
35,1457,1,1,,29215204,14985,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
36,1460,1,3,,26754431,14985,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
37,1460,1,3,,29215204,14985,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
38,1463,1,1,,26754431,14985,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
39,1463,1,1,,29215204,14985,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
40,1465,1,1,,47193687,14985,Inactive,,,,EC50,"Screen for small molecule probes relevant to Friedreich's ataxia, Single Dose and Dose Response",Confirmatory,,
41,1467,1,3,,26754431,14985,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
42,1467,1,3,,29215204,14985,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
43,1468,1,1,,26754431,14985,Inconclusive,92096784.0,4137.0,3.5481,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
44,1468,1,1,,29215204,14985,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
45,1469,1,1,,26754431,14985,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
46,1469,1,1,,29215204,14985,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
47,1469,1,1,,29215205,14985,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
48,1471,2,1,,26754431,14985,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
49,1471,2,1,,29215204,14985,Inconclusive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
50,1476,2,1,,26754431,14985,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
51,1476,2,1,,29215204,14985,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
52,1477,1,1,,26754431,14985,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
53,1477,1,1,,29215204,14985,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
54,1477,1,1,,29215205,14985,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
55,1478,2,1,,26754431,14985,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
56,1478,2,1,,29215204,14985,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
57,1479,1,2,,26754431,14985,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
58,1479,1,2,,29215204,14985,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
59,1479,1,2,,29215205,14985,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
60,1487,1,1,,29215204,14985,Inconclusive,27436948.0,4000.0,0.1122,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
61,1490,2,1,,26754431,14985,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
62,1490,2,1,,29215204,14985,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
63,1490,2,1,,29215205,14985,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
64,1511,1,3,,47193687,14985,Inactive,487738.0,3757.0,,,Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents,Screening,,
65,1519,1,3,,26754431,14985,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
66,1529,1,1,,47193687,14985,Inactive,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
67,1530,1,1,,47193687,14985,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
68,1531,1,1,,47193687,14985,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
69,1532,1,1,,47193687,14985,Inactive,,,,,Rml C and D inhibition 384-well mixture HTS,Screening,,
70,1554,1,1,,47193687,14985,Inactive,,,,,MLPCN Ras selective lethality-BJeLR viability,Screening,,
71,1576,1,1,,57244287,14985,Inactive,,,,,DSSTox (KIERBL) EPA Estrogen Receptor Ki Binding Study (Laws et al.) Database,Other,,
72,1621,1,2,,47193687,14985,Inactive,,,,IC50,A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus,Confirmatory,,
73,1626,1,2,,47193687,14985,Inactive,,,,IC50,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
74,1662,1,2,,47193687,14985,Inactive,15675770.0,901648.0,,,MLPCN Streptokinase Expression Inhibition,Screening,,
75,1663,1,2,,47193687,14985,Inactive,,,,,MLPCN Platelet Activation -Dense Granule Release,Screening,,
76,1672,1,3,,47193687,14985,Inactive,6680530.0,16518.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1,Screening,,
77,1688,1,1,,29215204,14985,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
78,1766,1,1,,26754431,14985,Inconclusive,18860839.0,4221.0,39.8107,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
79,1766,1,1,,26754431,14985,Inconclusive,56550039.0,4297.0,39.8107,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
80,1766,1,1,,29215204,14985,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
81,1766,1,1,,29215204,14985,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
82,1766,1,1,,29215205,14985,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
83,1766,1,1,,29215205,14985,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
84,1768,1,1,,26754431,14985,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
85,1768,1,1,,26754431,14985,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
86,1768,1,1,,29215204,14985,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
87,1768,1,1,,29215204,14985,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
88,1768,1,1,,29215205,14985,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
89,1768,1,1,,29215205,14985,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
90,1813,1,2,,47193687,14985,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors,Screening,,
91,1814,1,2,,47193687,14985,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators,Screening,,
92,1832,2,1,,47193687,14985,Inactive,55976631.0,178296.0,,,MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen,Screening,,
93,1850,2,1,,47193687,14985,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
94,1863,2,1,,47193687,14985,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
95,1865,1,1,,26754431,14985,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
96,1865,1,1,,29215204,14985,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
97,1875,2,1,,47193687,14985,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Polyadenylation,Screening,,
98,1885,2,1,,47193687,14985,Inactive,,,,,Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication,Screening,,
99,1899,1,3,,47193687,14985,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
100,1903,2,3,,47193687,14985,Inactive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
101,1906,1,3,,47193687,14985,Inactive,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
102,1910,1,2,,47193687,14985,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Transcriptional Activators of Hypoxia-Inducible Factor Pathway,Screening,,
103,1947,1,2,,47193687,14985,Inactive,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
104,1948,1,1,,26754431,14985,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
105,1948,1,1,,29215204,14985,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
106,1950,1,3,,47193687,14985,Inactive,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
107,1956,1,1,,47193687,14985,Inactive,,,,Conc @ Max Fold Increase,A high-throughput screen to identify small molecule compounds that augment HSV replication,Confirmatory,,
108,1962,1,2,,47193687,14985,Inactive,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
109,1974,1,2,,47193687,14985,Inactive,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
110,1987,1,2,,47193687,14985,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
111,2016,1,3,,47193687,14985,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
112,2023,1,3,,47193687,14985,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
113,2025,1,3,,47193687,14985,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
114,2029,1,3,,47193687,14985,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
115,2052,2,1,,47193687,14985,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
116,2057,1,2,,47193687,14985,Inactive,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
117,2066,1,4,,47193687,14985,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
118,2094,1,2,,47193687,14985,Inactive,67463988.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
119,2094,1,2,,47193687,14985,Inactive,67463989.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
120,2094,1,2,,47193687,14985,Inactive,166202459.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
121,2097,1,2,,47193687,14985,Inactive,21361340.0,2932.0,,,Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity,Screening,,
122,2098,1,1,,47193687,14985,Inactive,62740231.0,15499.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1).,Screening,,
123,2099,1,1,,47193687,14985,Inactive,,,,,Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity,Screening,,
124,2101,1,1,,26754431,14985,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
125,2101,1,1,,29215204,14985,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
126,2101,1,1,,29215205,14985,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
127,2107,1,1,,26754431,14985,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
128,2107,1,1,,29215204,14985,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
129,2107,1,1,,29215205,14985,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
130,2112,1,1,,26754431,14985,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
131,2112,1,1,,29215204,14985,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
132,2112,1,1,,29215205,14985,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
133,2129,1,2,,47193687,14985,Inactive,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
134,2130,1,3,,47193687,14985,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
135,2147,1,1,,26754431,14985,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
136,2156,2,2,,47193687,14985,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels,Screening,,
137,2174,1,3,,47193687,14985,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
138,2177,1,3,,47193687,14985,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
139,2216,1,3,,47193687,14985,Inactive,,,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex,Screening,,
140,2221,1,2,,47193687,14985,Inactive,15609874.0,888371.0,,,Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity,Screening,,
141,2227,1,2,,47193687,14985,Inactive,2935630.0,22066.0,,,Primary cell-based high-throughput screening assay for identification of compounds that allosterically potentiate transient receptor potential cation channel C4 (TRPC4),Screening,,
142,2234,1,2,,47193687,14985,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
143,2235,1,2,,47193687,14985,Inactive,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
144,2237,1,2,,47193687,14985,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4).,Screening,,
145,2239,1,2,,47193687,14985,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels,Screening,,
146,2247,1,2,,47193687,14985,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4).,Screening,,
147,2280,2,3,,47193687,14985,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
148,2300,1,3,,47193687,14985,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
149,2314,1,2,,29215204,14985,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
150,2314,1,2,,29215204,14985,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
151,2314,1,2,,29215205,14985,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
152,2314,1,2,,29215205,14985,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
153,2315,1,2,,29215204,14985,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
154,2315,1,2,,29215204,14985,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
155,2315,1,2,,29215205,14985,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
156,2315,1,2,,29215205,14985,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
157,2380,1,2,,47193687,14985,Inactive,,,,,uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line,Screening,,
158,2391,1,1,,47193687,14985,Inactive,,,,IC50,A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV),Confirmatory,,
159,2435,1,2,,47193687,14985,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
160,2445,1,2,,47193687,14985,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
161,2451,1,2,,26754431,14985,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
162,2451,1,2,,29215204,14985,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
163,2451,1,2,,29215205,14985,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
164,2462,1,1,,47193687,14985,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
165,2462,1,1,,47193687,14985,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
166,2472,1,2,,26754431,14985,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
167,2472,1,2,,29215204,14985,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
168,2472,1,2,,29215205,14985,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
169,2517,2,1,,26754431,14985,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
170,2517,2,1,,29215205,14985,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
171,2520,1,4,,47193687,14985,Inactive,4885057.0,187.0,,,uHTS identification of small molecule agonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
172,2521,1,3,,47193687,14985,Inactive,4885057.0,187.0,,,uHTS identification of small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
173,2524,1,2,,47193687,14985,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase,Screening,,
174,2528,1,2,,26754431,14985,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
175,2528,1,2,,29215204,14985,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
176,2528,1,2,,29215205,14985,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
177,2540,1,2,,47193687,14985,Inactive,262118306.0,123228.0,,,HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8),Screening,,
178,2544,1,2,,47193687,14985,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase,Screening,,
179,2546,1,1,,26754431,14985,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
180,2546,1,1,,29215204,14985,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
181,2546,1,1,,29215205,14985,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
182,2549,1,1,,26754431,14985,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
183,2549,1,1,,29215204,14985,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
184,2549,1,1,,29215205,14985,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
185,2550,1,3,,47193687,14985,Inactive,160333370.0,22068.0,,,High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6),Screening,,
186,2551,1,1,,26754431,14985,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
187,2551,1,1,,29215204,14985,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
188,2551,1,1,,29215205,14985,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
189,2553,1,2,,47193687,14985,Inactive,160333370.0,22068.0,,,High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6),Screening,,
190,2557,1,3,,47193687,14985,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
191,2563,1,1,,47193687,14985,Inactive,6323930.0,855317.0,,,Fluorescence Cell-Free Homogenous Primary HTS  to Identify Inhibitors of the Ras-converting Enzyme,Screening,,
192,2599,1,2,,47193687,14985,Inactive,6166485.0,26054.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6),Screening,,
193,2606,1,2,,47193687,14985,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
194,2629,1,1,,47193687,14985,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
195,2642,1,2,,47193687,14985,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels,Screening,,
196,2648,1,2,,47193687,14985,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels,Screening,,
197,2650,2,1,,47193687,14985,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
198,2661,1,1,,47193687,14985,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
199,2662,2,1,,29215204,14985,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
200,2690,1,2,,47193687,14985,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
201,2716,1,1,,47193687,14985,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
202,2717,1,2,,47193687,14985,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
203,2718,1,1,,47193687,14985,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
204,2751,2,2,,47193687,14985,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
205,2796,1,4,,47193687,14985,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
206,2797,1,2,,47193687,14985,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
207,2805,2,2,,47193687,14985,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase,Screening,,
208,2806,2,2,,47193687,14985,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase,Screening,,
209,2825,1,2,,47193687,14985,Inactive,219518789.0,114548.0,,,uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast,Screening,,
210,7131,4,9,,103166767,14985,Unspecified,729945.0,25290.0,,,Inhibition of 5-lipoxygenase of rat basophilic leukemia cells at 30 uM,Other,9484493.0,
211,42807,5,2,,103166767,14985,Unspecified,,,,,Inhibition of [Fe(2+)]/ascorbate-induced oxidation of bovine heart membranes(antioxidant BHMLO),Other,9925732.0,
212,45821,5,2,,103166767,14985,Inconclusive,,,,,The compound was evaluated for percent reduction of H2O2-induced H2DCFDA fluorescence in human CEM T-cells; No data,Other,10636251.0,
213,48968,6,2,,103166767,14985,Active,,,1.5,IC50,Concentration of the test compound required to inhibit the auto oxidative lipid peroxidations in canine brain homogenates by 50% was determined,Confirmatory,12113815.0,
214,50632,6,1,,103166767,14985,Unspecified,,,,,Compound is evaluated for the effect on lipid metabolism in 6-week-old male chickens at a concentration of 20 ppm in the diet and measured for HDL cholesterol,Other,1433170.0,
215,50641,3,3,,103166767,14985,Unspecified,,,,,picomoles of mevalonic acid synthesized per minute per mg of microsomal protein,Other,1433170.0,
216,50653,6,1,,103166767,14985,Unspecified,,,,,Compound is evaluated for the effect on lipid metabolism in 6-week-old male chickens at a concentration of 20 ppm in the diet and measured for LDL cholesterol,Other,1433170.0,
217,51430,6,1,,103166767,14985,Unspecified,,,,,Compound is evaluated for the effect on lipid metabolism in 6-week-old male chickens at a concentration of 20 ppm in the diet and measured for total cholesterol,Other,1433170.0,
218,53443,3,4,,103166767,14985,Inconclusive,,,,,Tested for anticonvulsant effects on audiogenic seizures in DBA/2 mice; administered intra peritonealy; NT denotes not tested,Other,10978184.0,
219,54305,3,3,,103166767,14985,Unspecified,,,,,Tested for antioxidant activity using bovine heart mitochondria and iron(II) / dihydroxy fumaric acid (DHF) at 100 uM,Other,8496914.0,
220,63632,3,8,,103166767,14985,Inconclusive,,,,,Concentration required for 50% inhibitory effect on Dopamine receptor D2 determined in competition experiments with [3H]raclopride; NT denotes not tested,Other,10978184.0,
221,68460,6,2,,103166767,14985,Active,,,5.9,IC50,"Inhibitory activity against lipid peroxidation of egg-phosphatidylcholine (PC) liposome caused by lipid-soluble radical initiator [2,2'-azobis(2,4- dimethylvaleronitrile] (AMVN)",Confirmatory,9873437.0,
222,68587,6,2,,103166767,14985,Active,,,40.3,IC50,"Inhibitory activity against lipid peroxidation of egg-phosphatidylcholine (PC) liposome caused by water-soluble radical initiator [2,2'-azobis(2-amidinopropane) dihydrochloride] (AAPH)",Confirmatory,9873437.0,
223,76079,6,2,,103166767,14985,Unspecified,,,280.0,IC50,Inhibition of CCl4 induced lipid peroxidation (LPO) of guinea pig hepatic microsomes at 300 uM concentration,Confirmatory,9484493.0,
224,78013,6,3,,103166767,14985,Unspecified,,,280.0,IC50,Antioxidative activity was evaluated by using the lipid peroxidation of guinea pig liver microsomes,Confirmatory,10230633.0,
225,78571,6,2,,103166767,14985,Unspecified,,,,,Percentage inhibition of cell growth in the presence of compound in H69/LX4 cells with B669 as inhibitor; reversal of inhibition,Other,15012986.0,
226,78572,6,2,,103166767,14985,Unspecified,,,,,Percentage inhibition of cell growth in the presence of compound in H69/LX4 cells with Clofazemine as inhibitor; reversal of inhibition,Other,15012986.0,
227,78573,6,2,,103166767,14985,Unspecified,,,,,Percentage inhibition of cell growth in the presence of compound in H69/LX4 cells with as GG918 inhibitor; reversal of inhibition,Other,15012986.0,
228,78574,6,2,,103166767,14985,Unspecified,,,,,Percentage inhibition of cell growth in the presence of compound in H69/LX4 cells with verapamil as inhibitor; reversal of inhibition,Other,15012986.0,
229,81332,3,4,,103166767,14985,Unspecified,,,,,Compound was evaluated for in vitro inhibition of proliferation measured by inhibition of [3H]thymidine incorporation by HMVEC-L cells,Other,9925732.0,
230,85735,7,1,,103166767,14985,Unspecified,,,,,"Maximum tolerated concentration required for neurotoxicity on murine HT-22 hippocampal cell culture, monitored by LDH assay tested in vitro",Other,10571150.0,
231,85736,7,1,,103166767,14985,Unspecified,,,,,"Maximum tolerated concentration required for neurotoxicity on murine HT-22 hippocampal cell culture, monitored by MTT reduction assay tested in vitro",Other,10571150.0,
232,85737,7,1,,103166767,14985,Active,,,,,Compound was tested in vitro for its neuroprotective activity against L-homocysteic acid(L-HCA) cytotoxicity in murine HT-22 hippocampal cell culture monitored by MTT reduction assay,Other,10571150.0,
233,85738,7,1,,103166767,14985,Active,,,,,"Tested in vitro for its neuroprotective activity against L-homocysteic acid(L-HCA) cytotoxicity, in murine HT-22 hippocampal cell culture, monitored by LDH assay.",Other,10571150.0,
234,85742,8,1,,103166767,14985,Unspecified,,,200.0,TC50,"Tested in vitro for neurotoxicity on murine HT-22 hippocampal cell culture, monitored by LDH assay.",Confirmatory,10571150.0,
235,85743,8,1,,103166767,14985,Unspecified,,,200.0,TC50,"Tested in vitro for neurotoxicity on murine HT-22 hippocampal cell culture, monitored by MTT reduction assay",Confirmatory,10571150.0,
236,85744,7,1,,103166767,14985,Unspecified,,,,,The minimum tolerated concentration by MTT reduction assay in HT-22 hippocampal cell line.,Other,10853663.0,
237,85745,7,1,,103166767,14985,Active,,,,,The concentration producing 50% protection against L-HCA-mediated neurotoxicity in HT-22 hippocampal cell line.,Other,10853663.0,
238,85747,5,2,,103166767,14985,Inconclusive,,,,,The concentration producing 50% toxicity in HT-22 hippocampal cell line; No data,Other,10853663.0,
239,88960,6,3,,103166767,14985,Active,,,13.6,IC50,Compound was evaluated for the inhibition of HUVEC-induced LDL oxidation,Confirmatory,,
240,88961,6,3,,103166767,14985,Active,,,10.0,IC50,Compound was evaluated for the inhibition of human LDL oxidation mediated by copper(II).,Confirmatory,,
241,91550,6,1,,103166767,14985,Unspecified,,,,,"Evaluated for neuronal cell protectivity against beta-amyloid (25,35) insult towards IMR-32 human neuroblastoma cell; No protection",Other,11549465.0,
242,103204,6,2,,103166767,14985,Unspecified,,,329.0,IC50,Compound was tested for antiproliferative activity against human breast cancer cell line MCF-7 in MTT assay,Confirmatory,9873556.0,
243,119179,4,3,,103166767,14985,Unspecified,,,,,Time of recovery of righting reflux (RRT) in seconds was measured after administration of 100 mg/kg orally in mice for the promotional effect on recovery from coma,Other,1676756.0,
244,119180,3,3,,103166767,14985,Unspecified,,,,,Time of recovery of righting reflux (RRT) in seconds was measured after administration of 100 mg/kg orally in mice for the promotional effect on recovery from coma.,Other,1676757.0,
245,119258,4,3,,103166767,14985,Unspecified,,,,,Time of recovery of spontaneous movement (SMT) in seconds was measured after administration of 100 mg/kg orally in mice for the promotional effect on recovery from coma,Other,1676756.0,
246,119259,3,3,,103166767,14985,Unspecified,,,,,Time of recovery of spontaneous movement (SMT) in seconds was measured after administration of 100 mg/kg orally in mice for the promotional effect on recovery from coma.,Other,1676757.0,
247,119424,3,3,,103166767,14985,Unspecified,,,,,Antihypoxic effect by the ratio of survival time (SVT) of test mice to that of control group at a dose of 100 mg/kg administered intraperitoneally.,Other,1676757.0,
248,119425,3,3,,103166767,14985,Unspecified,,,,,Antihypoxic effect by the ratio of survival time (SVT) of test mice to that of control group at a dose of 100 mg/kg administered orally.,Other,1676757.0,
249,119552,3,3,,103166767,14985,Unspecified,,,,,Antihypoxic effect by the survival time (SVT) in mice at a dose of 100 mg/kg administered intraperitoneally in mice,Other,1676756.0,
250,119554,4,3,,103166767,14985,Unspecified,,,,,Antihypoxic effect tested by the survival time (SVT) in mice at a dose of 100 mg/kg,Other,1676756.0,
251,144633,5,2,,103166767,14985,Inconclusive,,,,,The compound was evaluated for percent reduction of H2O2-induced H2DCFDA fluorescence in NALM-6-B-cells;No data,Other,10636251.0,
252,156509,6,1,,103166767,14985,Unspecified,,,,,"Evaluated for neuronal cell protectivity against beta-amyloid (25,35) insult towards PC12 rat pheochromocytoma cell; No protection",Other,11549465.0,
253,160738,4,10,,103166767,14985,Unspecified,3914304.0,443460.0,,,Inhibition of Prostaglandin G/H synthase 2 from sheep placenta at 300 uM,Other,9484493.0,
254,162158,4,10,,103166767,14985,Unspecified,754286265.0,443551.0,,,Inhibition of Prostaglandin G/H synthase 1 isolated from ram (sheep) seminal vesicle at 300 uM,Other,9484493.0,
255,166113,3,7,,103166767,14985,Unspecified,126398.0,547923.0,,,In vitro inhibition of rabbit LDL oxidation by soybean lipoxygenase at 5 uM,Other,9784106.0,
256,166114,3,7,,103166767,14985,Unspecified,126398.0,547923.0,,,In vitro inhibition of rabbit LDL oxidation by soybean lipoxygenase at 0.5 uM,Other,9784106.0,
257,169998,3,3,,103166767,14985,Unspecified,,,,,"Effect of AOS scavenger on premeture ventricular complexes PVCs, arrhythmias induced by ischemia-reperfusion in anesthetized rat, duration at 3 mg/kg",Other,3351858.0,
258,173159,4,3,,103166767,14985,Unspecified,,,,,Antilipid peroxidation was determined,Other,3351858.0,
259,174640,3,3,,103166767,14985,Unspecified,,,,,"Effect of AOS scavenger on ventricular fibrillation (VF), arrhythmias induced by ischemia-reperfusion in anesthetized rat, duration at 3 mg/kg",Other,3351858.0,
260,174773,3,3,,103166767,14985,Unspecified,,,,,"Effect of AOS scavenger on ventricular tachycardia (VT), arrhythmias induced by ischemia-reperfusion in anesthetized rat, duration at 3 mg/kg",Other,3351858.0,
261,179358,3,3,,103166767,14985,Unspecified,,,,,"Effect of AOS scavenger on ventricular fibrillation (VF), arrhythmias induced by ischemia-reperfusion in anesthetized rat, frequency, times at 3 mg/kg",Other,3351858.0,
262,179368,3,3,,103166767,14985,Unspecified,,,,,"Effect of AOS scavenger on ventricular tachycardia (VT), arrhythmias induced by ischemia-reperfusion in anesthetized rat, frequency, times at 3 mg/kg",Other,3351858.0,
263,179395,6,2,,103166767,14985,Unspecified,,,100.0,IC50,Concentration required for 50% inhibitory effect on automatic oxidation in plasma membrane of rat brain homogenates by measuring malondialdehyde and 4-hydroxyalkenals using peroxidized lipid colorimetric assay kit.,Confirmatory,10978184.0,
264,180509,6,2,,103166767,14985,Active,,,28.0,IC50,"Tested in vitro for the inhibition of iron-dependent lipid peroxidation against rat brain homogenates, by malondialdehyde (MDA) formation assay",Confirmatory,1447746.0,
265,181514,6,2,,103166767,14985,Active,,,30.0,IC50,Ability to inhibit iron-dependent lipid peroxidation in rat brain homogenate using MDA (malondialdehyde) formation assay,Confirmatory,2319560.0,
266,181702,6,2,,103166767,14985,Unspecified,,,,,Evaluated for its antioxidative effect using the thiobarbituric acid (TBA) method in rat,Other,7913134.0,
267,181705,6,2,,103166767,14985,Active,,,12.0,IC50,Compound was evaluated for prevention of spontaneous lipid peroxidation in rat brain homogenate.,Confirmatory,1992125.0,
268,182346,3,3,,103166767,14985,Unspecified,,,,,Compound was tested for antioxidative activity using TBA method at a concentration of 200 ug/mL.,Other,9873651.0,
269,183773,3,3,,103166767,14985,Unspecified,,,,,"Effect of AOS scavenger on ventricular fibrillation (VF), arrhythmias induced by ischemia-reperfusion in anesthetized rat, incidence at 3 mg/kg; 8/10",Other,3351858.0,
270,183784,3,3,,103166767,14985,Unspecified,,,,,"Effect of AOS scavenger on ventricular tachycardia (VT), arrhythmias induced by ischemia-reperfusion in anesthetized rat, incidence at 3 mg/kg; 8/10",Other,3351858.0,
271,187612,3,3,,103166767,14985,Unspecified,,,,,"Reducing activity determined by the use of stable radical alpha,alpha-di-phenyl-beta-picrylhydrazyl (DPPH)",Other,3351858.0,
272,188642,3,3,,103166767,14985,Inconclusive,,,,,PD2 value was calculated as -log value of the concentration of the test compound to inhibit 60 mM KCl-induced contractions to 50% expressed as calcium antagonistic activity; No data,Other,12113815.0,
273,189715,3,3,,103166767,14985,Unspecified,,,,,In vitro inhibitory activity against rat microsomal lipid peroxidation (m-LPO),Other,2913302.0,
274,194997,5,2,,103166767,14985,Inactive,,,,,Inhibitory concentration required to inhibit cholesterol synthesis in isolated rat Hepatocytes; no inhibition,Other,1433170.0,
275,194999,4,3,,103166767,14985,Unspecified,,,,,Compound is evaluated for the inhibition of cholesterol biosynthesis in isolated rat hepatocytes at the concentration 250 (ug/mL),Other,1433170.0,
276,195001,4,3,,103166767,14985,Unspecified,,,,,Compound is evaluated for the inhibition of cholesterol biosynthesis in isolated rat hepatocytes at the concentration 500 ug/mL,Other,1433170.0,
277,195009,3,3,,103166767,14985,Unspecified,,,,,Percent inhibition at 250 ug/mL of binary mixtures of compound and alpha-tocotrienol on cholesterol synthesis in rat hepatocytes,Other,1433170.0,
278,195010,3,3,,103166767,14985,Unspecified,,,,,Percent inhibition at 250 ug/mL of binary mixtures of compound and delta-tocotrienol on cholesterol synthesis in rat hepatocytes,Other,1433170.0,
279,195011,3,3,,103166767,14985,Unspecified,,,,,Percent inhibition at 250 ug/mL of binary mixtures of compound and gamma-tocotrienol on cholesterol synthesis in rat hepatocytes,Other,1433170.0,
280,195012,3,3,,103166767,14985,Unspecified,,,,,Percent inhibition of cholesterol biosynthesis in rat hepatocytes at a concentration of 210 (micro g/mL),Other,1433170.0,
281,195017,6,2,,103166767,14985,Unspecified,,,,,LPO-lowering activity was estimated by the IC50 value of compound in rat liver microsomal lipid peroxidation,Other,2329571.0,
282,195018,3,4,,103166767,14985,Unspecified,,,,,The concentration of compound required to inhibit generation of superoxide by 50 percent in rat liver,Other,2329571.0,
283,195193,6,3,,103166767,14985,Unspecified,,,60.2,IC50,Compound was tested in vitro for [Ca2+] antagonistic activity in K+-depolarized isolated rat aorta,Confirmatory,10447958.0,
284,195549,6,2,,103166767,14985,Active,,,14.0,IC50,In vitro inhibition of lipid autoxidation (TBARS formation) of rat brain homogenate,Confirmatory,7853338.0,
285,195714,6,2,,103166767,14985,Active,,,4.68,IC50,Compound was tested for its inhibitory concentration against formation of lipid peroxides in rat brain homogenates by thiobarbituric acid reactive substances (TBARS) assay according to the method of Stocks.,Confirmatory,12182869.0,
286,196205,6,2,,103166767,14985,Active,,,13.2,IC50,Compound was tested for [Ca2+] overload inhibitory activity in the veratridine-induced [Ca2+] overload model of rat cardiac myocytes.,Confirmatory,10447958.0,
287,197786,8,4,,103166767,14985,Inconclusive,,,,,Compound was evaluated for the inhibition of recombinant HIV-1 reverse transcriptase; No data,Other,10636251.0,
288,225222,6,1,,103166767,14985,Unspecified,,,,,Antioxidative property against stable murine-murine hybridoma (Mark 3) cell line,Other,10794693.0,
289,227510,7,1,,103166767,14985,Active,,,,,Glutathione peroxidase-like activity at 10x(E -2) M concentration as NADP+/L/min,Other,10794693.0,
290,227511,7,1,,103166767,14985,Active,,,,,Glutathione peroxidase-like activity at 10x(E -3) M concentration as NADP+/L/min,Other,10794693.0,
291,227512,7,1,,103166767,14985,Active,,,,,Glutathione peroxidase-like activity at 10x(E -4) M concentration measured as NADP+/L/min,Other,10794693.0,
292,227649,3,6,,103166767,14985,Inconclusive,,,,,Inhibition of low-threshold (T-type) Calcium [Ca2+] currents in primary cultured rat cerebrocortical neurons using whole-cell voltage-clamp recording technique; (not tested),Other,10978184.0,
293,227651,3,10,,103166767,14985,Inconclusive,116447.0,81574.0,,,"Inhibition of veratridine-induced depolarization of rat cerebrocortical synaptosomes using a membrane potential sensitive fluorescent dye, rhodamine 6G; NT denotes not tested",Other,10978184.0,
294,227651,3,10,,103166767,14985,Inconclusive,116448.0,24766.0,,,"Inhibition of veratridine-induced depolarization of rat cerebrocortical synaptosomes using a membrane potential sensitive fluorescent dye, rhodamine 6G; NT denotes not tested",Other,10978184.0,
295,227651,3,10,,103166767,14985,Inconclusive,116449.0,497770.0,,,"Inhibition of veratridine-induced depolarization of rat cerebrocortical synaptosomes using a membrane potential sensitive fluorescent dye, rhodamine 6G; NT denotes not tested",Other,10978184.0,
296,228862,6,3,,103166767,14985,Unspecified,,,377.0,EC50,Antioxidant activity was evaluated by measuring the inhibition of oxidation of ABTS to ABTS+ by metmyoglobin in the presence of H2O2.,Confirmatory,10636251.0,
297,228869,7,2,,103166767,14985,Active,,,19.0,EC50,Free radical scavenging assessed as 50% reduction in DPPH absorbance (516 nm),Confirmatory,11784150.0,
298,230361,7,1,,103166767,14985,Active,,,,,"Reducing activity to scavenge 10 uM 1, 1-diphenylpicrylhydrazyl (DPPH)",Other,8496914.0,
299,232026,3,4,,103166767,14985,Unspecified,,,,,Safety ratio of MTC to that of PC50,Other,10853663.0,
300,232873,3,4,,103166767,14985,Unspecified,,,,,Free radical scavenging assessed as color reduction of DPPH,Other,11784150.0,
301,232978,3,3,,103166767,14985,Unspecified,,,,,Glutathione peroxidase-like activity in relation to Ebselen glutathione peroxidase-like activity,Other,10794693.0,
302,234580,5,2,,103166767,14985,Inactive,,,,,Inhibition time for 20 uM during peroxidation of liposomal suspension of dilinoleoylphosphatidylcholine (DPLC) indicated by DMVN at 40 degree centigrade; inactive,Other,8496914.0,
303,234581,3,3,,103166767,14985,Unspecified,,,,,Inhibition time for 20 uM during peroxidation of methyl linoleate / DMVN in TBA /methanol medium at 40 degree Centigrade,Other,8496914.0,
304,235827,3,3,,103166767,14985,Unspecified,,,,,Safety index (MTC/PC50),Other,10571150.0,
305,246424,6,2,,103166767,14985,Unspecified,,,,,Effective concentration required for scavenging of superoxide anion radical generation from the tentical protein of jellyfish,Other,15863337.0,
306,247699,6,2,,103166767,14985,Active,,,4.68,IC50,Inhibitory concentration against lipid peroxidation in rat,Confirmatory,15686926.0,
307,248417,6,2,,103166767,14985,Active,,,1.5,IC50,inhibitory concentration against auto-oxidative lipid peroxidation in canine brain homogenate,Confirmatory,15261288.0,
308,248562,8,2,,103166767,14985,Inactive,,,,,Inhibitory concentration against bovine serum albumin glycation; Not active from 3.80 nM to 1.00 mM,Other,15686926.0,
309,248585,8,2,,103166767,14985,Inactive,,,,,Inhibitory concentration against glycation in rat was determined; Not active from 3.80 nM to 1.00 mM,Other,15686926.0,
310,250422,3,3,,103166767,14985,Inactive,,,,,inhibition of LPS-induced TNF-alpha production in mouse MMGT12 cells at 1e-5 M to 1e-7 M concentration; No effect,Other,15546721.0,
311,256805,3,4,,103166767,14985,Unspecified,,,,,Ability to inhibit HMEC1-mediated LDL oxidation at 10 uM evaluated by TBARS formation in the presence of copper,Other,16366593.0,
312,256806,3,4,,103166767,14985,Unspecified,,,,,Cytotoxic effect of LDL oxidized by HMEC1 cells at 10 uM by MTT assay expressed as percentage of viability in unstimulated control,Other,16366593.0,
313,263481,4,3,,103166767,14985,Unspecified,,,,,Effect on CumOOH-induced oxidative damage of herring sperm DNA assessed as reduction in 8-OHdG level,Other,16458004.0,
314,263482,4,3,,103166767,14985,Unspecified,,,,,Effect on glutathione/ferric ion-induced oxidative damage of herring sperm DNA assessed as reduction in 8-OHdG level,Other,16458004.0,
315,276002,6,2,,103166767,14985,Active,,,8.8,IC50,ABTS radical scavenging activity,Confirmatory,16908141.0,
316,276003,6,2,,103166767,14985,Unspecified,,,100.0,IC50,Superoxide anion radical scavenging activity by xanthine/xanthine oxidase method,Confirmatory,16908141.0,
317,276004,6,2,,103166767,14985,Active,,,11.5,IC50,DPPH radical scavenging activity,Confirmatory,16908141.0,
318,283657,3,3,,103166767,14985,Unspecified,,,,,"Reduction in incidence of 600 mg/kg, sc ciprofloxacin-induced cartilage lesions in vitamin E-enriched diet fed immature Wistar rat after 10 days",Other,17210779.0,
319,287012,6,3,,103166767,14985,Active,,,0.9,IC50,Antioxidant activity in rat liver microsomes assessed as inhibition of ferrous-cystine-induced lipid peroxidation after 15 mins,Confirmatory,17461599.0,
320,287995,6,3,,103166767,14985,Unspecified,,,100.0,IC50,Antioxidant activity assessed as DPPH radical scavenging activity,Confirmatory,17387019.0,
321,287996,6,2,,103166767,14985,Active,,,3.4,IC50,Antioxidant activity assessed as superoxide radical anion scavenging activity,Confirmatory,17387019.0,
322,287997,6,2,,103166767,14985,Active,,,11.6,IC50,Antioxidant activity assessed as ABTS radical scavenging activity,Confirmatory,17387019.0,
323,288080,7,1,,103166767,14985,Unspecified,,,,,Effect on glutathione peroxidase activity in V79 cells at 30 uM after 24 hrs,Other,17391968.0,
324,288081,6,1,,103166767,14985,Unspecified,,,,,Effect on superoxide dismutase activity in V79 cells at 30 uM after 24 hrs,Other,17391968.0,
325,288082,6,1,,103166767,14985,Unspecified,,,,,Effect on catalase activity in V79 cells at 30 uM after 24 hrs,Other,17391968.0,
326,288083,6,1,,103166767,14985,Unspecified,,,,,Effect on malondialdehyde level in V79 cells at 30 uM after 24 hrs,Other,17391968.0,
327,288084,6,1,,103166767,14985,Unspecified,,,,,Effect on dityrosine level in V79 cells at 30 uM after 24 hrs,Other,17391968.0,
328,288085,3,5,,103166767,14985,Unspecified,,,,,Effect on 8-hydroxy-deoxyguanosine level in V79 cells at 30 uM after 24 hrs,Other,17391968.0,
329,290179,6,2,,103166767,14985,Active,,,2.3,IC50,Inhibition of DPPH radical scavenging activity,Confirmatory,17197183.0,
330,292583,3,3,,103166767,14985,Unspecified,,,,,DPPH radical scavenging activity at 100 uM,Other,17608535.0,
331,292584,3,3,,103166767,14985,Unspecified,,,,,DPPH radical scavenging activity at 50 uM,Other,17608535.0,
332,292585,3,3,,103166767,14985,Unspecified,,,,,DPPH radical scavenging activity at 25 uM,Other,17608535.0,
333,292586,3,3,,103166767,14985,Unspecified,,,,,DPPH radical scavenging activity at 12.5 uM,Other,17608535.0,
334,292587,3,3,,103166767,14985,Unspecified,,,,,DPPH radical scavenging activity at 6.25 uM,Other,17608535.0,
335,292621,5,1,,103166767,14985,Inactive,,,,,Cytotoxicity against human 1A9 cells by sulforhodamine B assay,Other,17643301.0,
336,292622,5,1,,103166767,14985,Inactive,,,,,Cytotoxicity against human KB cells by sulforhodamine B assay,Other,17643301.0,
337,292623,5,1,,103166767,14985,Inactive,,,,,Cytotoxicity against human A549 cells,Other,17643301.0,
338,292624,5,1,,103166767,14985,Inactive,,,,,Cytotoxicity against human HCT8 cells,Other,17643301.0,
339,292625,5,1,,103166767,14985,Unspecified,,,,,Cytotoxicity against human A431 cells,Other,17643301.0,
340,292626,5,1,,103166767,14985,Inactive,,,,,Cytotoxicity against MDR human KB-VIN cells expressing P-glycoprotein,Other,17643301.0,
341,298198,3,4,,103166767,14985,Unspecified,,,,,Antioxidant activity in Sprague-Dawley Albino rat brain assessed as inhibition of TBARS production at 100 uM relative to control,Other,17845019.0,
342,300693,4,3,,103166767,14985,Unspecified,,,,,Effect on HMEC1 cells-mediated LDL oxidation at 10 uM after 6 hrs by TBARS assay,Other,17624792.0,
343,300695,4,3,,103166767,14985,Unspecified,,,,,Cytoprotective effect on HMEC1 cells assessed as cell viability by MTT assay,Other,17624792.0,
344,300696,3,3,,103166767,14985,Unspecified,,,,,Cytoprotective effect on HMEC1 cells assessed as cell viability at 10 uM after 24 hrs by MTT assay,Other,17624792.0,
345,307146,3,3,,103166767,14985,Unspecified,,,,,"Protective effect against ischemia/reperfusion-induced microvascular damages in golden hamster assessed as number of leakage site per cm^2 at 10 mg/kg, po after 10 mins by cheek pouch assay",Other,17379527.0,
346,307147,3,3,,103166767,14985,Unspecified,,,,,"Protective effect against ischemia/reperfusion-induced microvascular damages in golden hamster assessed as number of leakage site per cm^2 at 10 mg/kg, po after 15 mins by cheek pouch assay",Other,17379527.0,
347,308942,6,2,,103166767,14985,Unspecified,,,500.0,IC50,Cytotoxicity against human THP1 cells by MTT assay,Confirmatory,17627828.0,
348,308943,6,2,,103166767,14985,Unspecified,,,500.0,IC50,Cytotoxicity against mouse J774 cells by MTT assay,Confirmatory,17627828.0,
349,309192,6,2,,103166767,14985,Active,,,9.89,IC50,DPPH radical scavenging activity after 30 mins,Confirmatory,17693086.0,
350,311873,6,2,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH reducing activity,Other,18004816.0,
351,314540,6,2,,103166767,14985,Active,,,4.68,IC50,Inhibition of lipid peroxidation in Sprague-Dawley rat brain after 30 mins by TBARS assay,Confirmatory,18249541.0,
352,318324,3,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as ABTS radical scavenging activity,Other,18324763.0,
353,323921,3,3,,103166767,14985,Active,,,,,Enhancement of HCV RNA replication in OR6 cells after 72 hrs by luciferase reporter assay,Other,17420205.0,
354,323924,3,3,,103166767,14985,Active,,,,,Antiviral activity against HCV assessed as suppression of HCV RNA replication in ORN/C-5B/KE/poly cells after 72 hrs by luciferase reporter assay,Other,17420205.0,
355,323925,3,3,,103166767,14985,Active,,,,,Antiviral activity against HCV assessed as suppression of HCV RNA replication in ORN/3-5B/KE/poly cells after 72 hrs by luciferase reporter assay,Other,17420205.0,
356,323926,3,3,,103166767,14985,Active,,,,,Enhancement of HCV RNA replication in ORN/C-5B/KE/poly cells after 72 hrs by luciferase reporter assay,Other,17420205.0,
357,323927,3,3,,103166767,14985,Inactive,,,,,Enhancement of HCV RNA replication in ORN/3-5B/KE/poly cells after 72 hrs by luciferase reporter assay,Other,17420205.0,
358,330319,3,3,,103166767,14985,Active,,,,,Increase in hepatitis C virus replication in Huh7-K2040 cells in presence of delipidated fetal calf serum medium at 0.3 uM by RT-PCR relative to control,Other,18003907.0,
359,330324,3,3,,103166767,14985,Active,,,,,Restoration of hepatitis C virus replication in Huh7-K2040 cells in presence of delipidated fetal calf serum medium in absence of arachidonate by RT-PCR relative to control,Other,18003907.0,
360,330325,3,3,,103166767,14985,Unspecified,,,,,Increase of hepatitis C virus replication in Huh7-K2040 cells in delipidated fetal calf serum medium in presence of arachidonate by RT-PCR relative to control,Other,18003907.0,
361,330326,3,4,,103166767,14985,Active,,,,,Restoration of hepatitis C virus replication in Huh7-K2040 cells in delipidated fetal calf serum medium assessed as increase in viral DNA level 40 nM in absence of arachidonate by RT-PCR relative to control,Other,18003907.0,
362,330327,3,3,,103166767,14985,Active,,,,,Increase of hepatitis C virus replication in Huh7-K2040 cells in delipidated fetal calf serum medium assessed as increase in viral DNA level at 40 nM in presence of arachidonate by RT-PCR relative to control,Other,18003907.0,
363,330328,3,3,,103166767,14985,Inactive,,,,,Increase of hepatitis C virus replication in Huh7-K2040 cells in fetal calf serum medium in absence of arachidonate by RT-PCR relative to control,Other,18003907.0,
364,330329,3,3,,103166767,14985,Inactive,,,,,Increase of hepatitis C virus replication in Huh7-K2040 cells in fetal calf serum medium in presence of arachidonate by RT-PCR relative to control,Other,18003907.0,
365,333687,6,3,,103166767,14985,Active,,,20.1,IC50,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins,Confirmatory,15620237.0,
366,334810,6,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as free radical scavenging activity,Other,,
367,337865,3,4,,103166767,14985,Active,,,,,Antioxidant activity assessed as inhibition of lipid peroxidation at 20 ug incubated at 40 degC in dark by paper disk method,Other,,
368,345789,12,1,,103166767,14985,Unspecified,,,,,Radical scavenging activity assessed as rate constant,Other,18976930.0,
369,345798,3,3,,103166767,14985,Active,,,,,Neuroprotective activity against glutamate-induced neuronal cell death in Sprague-Dawley rat primary cortical neuron at 2.5 uM pretreated for 24 hrs prior to glutamate challenge measured after 24 hrs by MTT assay,Other,18976930.0,
370,354424,6,3,,103166767,14985,Active,,,22.8,IC50,Antioxidant activity assessed as DPPH radical scavenging activity,Confirmatory,12608850.0,
371,354825,6,3,,103166767,14985,Unspecified,,,,,Inhibition of lipid peroxidation in rat liver microsomes,Other,8946751.0,
372,355800,3,5,,103166767,14985,Active,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity by TLC autoradiographic assay,Other,12762791.0,
373,355801,6,2,,103166767,14985,Unspecified,,,255.0,IC50,"Antioxidant activity against TPA-induced ROS production in human HL60 cells by 2',7'-dichlorodihydrofluorescein diacetate cellular-based assay",Confirmatory,12762791.0,
374,356108,3,4,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 6 uM after 30 mins,Other,12880316.0,
375,356109,3,4,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 12 uM after 30 mins,Other,12880316.0,
376,356110,3,4,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 23 uM after 30 mins,Other,12880316.0,
377,356111,3,4,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 58 uM after 30 mins,Other,12880316.0,
378,356112,3,4,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 115 uM after 30 mins,Other,12880316.0,
379,356113,3,4,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 230 uM after 30 mins,Other,12880316.0,
380,356114,9,1,,103166767,14985,Unspecified,,,,,ABTS radical scavenging activity assessed as trolox equivalents by TEAC assay,Other,12880316.0,
381,356115,9,1,,103166767,14985,Unspecified,,,,,Superoxide radical scavenging activity assessed as trolox equivalents by photochemiluminescence assay,Other,12880316.0,
382,356116,3,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition of FeSO4-induced lipid peroxidation at 8 uM by TBARS assay,Other,12880316.0,
383,356117,3,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition of FeSO4-induced lipid peroxidation at 16 uM by TBARS assay,Other,12880316.0,
384,356118,3,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition of FeSO4-induced lipid peroxidation at 33 uM by TBARS assay,Other,12880316.0,
385,356119,3,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition of FeSO4-induced lipid peroxidation at 82 uM by TBARS assay,Other,12880316.0,
386,356120,3,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition of FeSO4-induced lipid peroxidation at 164 uM by TBARS assay,Other,12880316.0,
387,356135,6,3,,103166767,14985,Active,,,8.3,IC50,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins,Confirmatory,12880321.0,
388,356306,6,2,,103166767,14985,Unspecified,,,250.0,IC50,Antioxidant activity in egg yolk liposomes assessed as inhibition of ADP/Fe(2+)-induced lipid peroxidation after 15 mins by TBARS method,Confirmatory,12932131.0,
389,356427,6,3,,103166767,14985,Active,,,8.3,IC50,Antioxidant activity assessed as DPPH free radical scavenging activity,Confirmatory,14510598.0,
390,357923,3,4,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 100 ug/mL,Other,11575963.0,
391,357936,6,3,,103166767,14985,Unspecified,,,,,Antioxidant activity in rat liver microsomes assessed as inhibition of lipid peroxidation by TBA method,Other,11575966.0,
392,358554,6,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity,Other,11170672.0,
393,360575,8,1,,103166767,14985,Active,,,4.0,IC50,Antioxidant activity assessed as inhibition of endothelial cell-induced human LDL oxidation,Confirmatory,8691205.0,
394,360576,10,1,,103166767,14985,Unspecified,,,100.0,IC50,Antioxidant activity assessed as inhibition of copper-induced human LDL oxidation,Confirmatory,8691205.0,
395,360662,3,4,,103166767,14985,Unspecified,,,,,"Antioxidant activity in phorbol 12-myristate 13-acetate-stimulated human HL60 cells assessed as inhibition of exogenous hydrogen peroxide-catalyzed oxidation of 2',7'-dichlorodihydrofluorescein diacetate at 50 ug/mL pretreated 30 mins before PMA challenge by flow cytometry",Other,11421725.0,
396,360861,4,4,,103166767,14985,Inactive,,,,,"Antioxidant activity in human HL60 cells assessed as inhibition of endogenous hydrogen peroxide-catalyzed oxidation of 2',7'-dichlorodihydrofluorescein diacetate at 50 ug/mL by flow cytometry",Other,11421725.0,
397,365747,8,1,,103166767,14985,Unspecified,,,78.0,ED50,Antioxidant activity assessed as DPPH radical scavenging activity,Confirmatory,18656366.0,
398,374048,3,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition microsomal lipid peroxidation at 100 ug/ml by thiobarbituric acid test,Other,18819730.0,
399,375988,6,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity relative to control,Other,16643034.0,
400,375989,6,2,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as superoxide anion scavenging activity by xanthine oxidase oxidation system relative to control,Other,16643034.0,
401,375991,3,3,,103166767,14985,Unspecified,,,,,"Antioxidant activity assessed as inhibition of 2,2'-azobis(2-amidinopropane)dihydrochloride-induced lipid peroxidation at 3.125 ug/ml by ferric thiocyanate system relative to control",Other,16643034.0,
402,376367,5,1,,103166767,14985,Unspecified,,,,,Antioxidant activity in brain homogenate assessed as drug level require to inhibit 50% of spontaneous lipid peroxidation relative to control,Other,10579855.0,
403,376397,3,4,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 20 uM after 30 mins,Other,10579867.0,
404,376398,3,4,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 40 uM after 30 mins,Other,10579867.0,
405,376400,3,4,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 10 uM after 30 mins,Other,10579867.0,
406,376418,3,3,,103166767,14985,Unspecified,,,,,Antioxidation activity assessed as inhibition of peroxidation of liposome at 4.31 ug/mL,Other,10579873.0,
407,376722,3,3,,103166767,14985,Active,,,,,Antioxidant activity assessed as inhibition of rate of formation of phosphatidylcholine hydroperoxides at 2.2 uM by phosphatidylcholine oxidation assay,Other,10654418.0,
408,376723,3,3,,103166767,14985,Active,,,,,Antioxidant activity in methanolic solution at 83 uM at 37 degC,Other,10654418.0,
409,377412,3,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition of lipid peroxidation at 300 uM by ferric thiocyanate method,Other,15730265.0,
410,377784,4,3,,103166767,14985,Inconclusive,,,,,Antioxidant activity assessed as ABTS radical scavenging activity after 15 mins by TEAC method,Other,15844940.0,
411,377785,6,2,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as reduction of F3+/ferricyanide complex after 20 mins,Other,15844940.0,
412,377786,3,4,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 15 ug/mL after 30 to 45 mins,Other,15844940.0,
413,379523,6,3,,103166767,14985,Active,,,37.5,IC50,Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins by multilabel counter,Confirmatory,17125238.0,
414,379803,6,3,,103166767,14985,Unspecified,,,,,Antioxidant activity in rat liver microsomes assessed as inhibition of lipid peroxidation by TBARS assay,Other,10346965.0,
415,380089,6,2,,103166767,14985,Active,,,6.0,IC50,Antioxidant activity assessed as ABTS radical scavenging activity after 12 hrs by ELISA,Confirmatory,16499338.0,
416,380372,3,3,,103166767,14985,Unspecified,,,,,DPPH radical scavenging activity at 80 uM after 30 mins by spectrophotometric assay,Other,10869193.0,
417,380373,3,3,,103166767,14985,Unspecified,,,,,DPPH radical scavenging activity at 40 uM after 30 mins by spectrophotometric assay,Other,10869193.0,
418,380374,3,3,,103166767,14985,Unspecified,,,,,DPPH radical scavenging activity at 20 uM after 30 mins by spectrophotometric assay,Other,10869193.0,
419,380375,3,3,,103166767,14985,Unspecified,,,,,DPPH radical scavenging activity at 10 uM after 30 mins by spectrophotometric assay,Other,10869193.0,
420,380376,3,3,,103166767,14985,Unspecified,,,,,DPPH radical scavenging activity at 5 uM after 30 mins by spectrophotometric assay,Other,10869193.0,
421,380377,3,3,,103166767,14985,Unspecified,,,,,DPPH radical scavenging activity at 2.5 uM after 30 mins by spectrophotometric assay,Other,10869193.0,
422,392229,3,4,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as reduction in lipid peroxidation in microsomes at 100 ug/mL measured as malondialdehyde formation by spectrophotometry relative to control,Other,19064319.0,
423,396342,3,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition of hydroxyl radical at 100 ug/mL,Other,18063225.0,
424,396343,3,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition of microsomal lipid peroxidation at 100 ug/mL,Other,18063225.0,
425,397153,11,1,,103166767,14985,Unspecified,,,,,Antioxidant activity against Cu2+-induced lipid peroxidation in human plasma LDL preincubated for 1 hr before Cu2+ challenge,Other,11325231.0,
426,397831,4,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 20 mins by UV-visible spectrophotometry,Other,12502312.0,
427,398696,6,4,,103166767,14985,Unspecified,,,102.0,IC50,Inhibition of lipid peroxidation in Sprague-Dawley rat heart mitochondria assessed as inhibition of FeSO4-induced oxygen consumption,Confirmatory,7494143.0,
428,398697,6,4,,103166767,14985,Unspecified,,,94.7,IC50,Inhibition of lipid peroxidation in Sprague-Dawley rat heart mitochondria assessed as inhibition of FeSO4-induced malondialdehyde formation,Confirmatory,7494143.0,
429,398700,3,5,,103166767,14985,Active,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 90 mins,Other,7494143.0,
430,398887,6,3,,103166767,14985,Unspecified,,,,,Inhibition of lipid peroxidation in rat liver microsome,Other,9249978.0,
431,400525,8,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity,Other,15043425.0,
432,402077,6,1,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as peroxide value relative to control,Other,9722496.0,
433,402708,3,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition of copper-induced lipid peroxidation by Fe3(CN)6 method at 300 uM,Other,16038556.0,
434,403038,6,3,,103166767,14985,Unspecified,,,350.0,IC50,Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins,Confirmatory,16124757.0,
435,403308,8,2,,103166767,14985,Unspecified,,,63.57,IC50,Antioxidant activity assessed as DPPH radical scavenging activity by HPLC,Confirmatory,15270574.0,
436,403309,3,3,,103166767,14985,Unspecified,,,,,DPPH radical scavenging activity assessed as ratio of IC50 for trolox to IC50 for test compound,Other,15270574.0,
437,406379,6,3,,103166767,14985,Active,,,18.1,IC50,Antioxidant activity assessed as DPPH free radical scavenging,Confirmatory,18512985.0,
438,407779,3,3,,103166767,14985,Unspecified,,,,,Antioxidant activity in HMEC1 cells assessed as inhibition of LDL oxidation at 10 uM after 6 hrs by TBARS assay relative to control,Other,18465848.0,
439,408062,3,3,,103166767,14985,Unspecified,,,,,Protection against oxidized LDL-induced cytotoxicity in HMEC1 cells assessed as residual cell viability after 24 hrs by MTT assay relative to control,Other,18465848.0,
440,412559,3,4,,103166767,14985,Active,,,,,"Cytoprotective activity against 20 uM rotenone-induced intracellular ROS production in human U937 cells at 100 uM pretreated for 5 hrs by 2,7-dichlorodihydrofluorescein dye reduction assay",Other,19072121.0,
441,412765,3,4,,103166767,14985,Active,,,,,Cytoprotective activity against 20 uM rotenone-induced intracellular ROS production in human U937 cells at 100 uM pretreated for 5 hrs by dihydroethidium dye reduction assay,Other,19072121.0,
442,420982,6,1,,103166767,14985,Inconclusive,,,,,Antimycobacterial activity against Mycobacterium bovis BCG Pasteur after 6 days by microdilution resazurin assay,Other,19232450.0,
443,420983,5,1,,103166767,14985,Unspecified,,,,,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 6 days by microdilution resazurin assay,Other,19232450.0,
444,420984,7,2,,103166767,14985,Inconclusive,,,,,Cytotoxicity against african green monkey Vero cells after 48 hrs by MTT assay,Other,19232450.0,
445,420986,3,4,,103166767,14985,Inactive,,,,,Antibacterial activity against Escherichia coli CIP188631 after 24 hrs by twofold serial dilution method,Other,19232450.0,
446,421702,3,6,,103166767,14985,Unspecified,,,,,Neuroprotective activity against H2O2-induced human SH-SY5Y cell damage assessed as increase in cell viability at 10 uM pretreated 2 hrs before H2O2 challenge relative to control,Other,19159273.0,
447,422292,9,1,,103166767,14985,Unspecified,,,,IC50,Antioxidant activity against beta-carotene and linoleic acid assessed as inhibition of bleaching of beta-carotene,Confirmatory,19215141.0,
448,422293,9,2,,103166767,14985,Unspecified,,,,IC50,Antioxidant activity assessed as DPPH radical scavenging activity,Confirmatory,19215141.0,
449,422294,6,2,,103166767,14985,Active,,,23.25,IC50,Antioxidant activity assessed as superoxide radical scavenging activity by phenazin methosulphate-NADH-NBT assay,Confirmatory,19215141.0,
450,425212,3,3,,103166767,14985,Unspecified,,,,,Protective activity against ischemia/reperfusion-induced increase in macromolecular permeability in po dosed golden hamster cheek pouch administered for 10 days,Other,19410467.0,
451,425214,3,3,,103166767,14985,Unspecified,,,,,Protective activity against histamine-induced increase in macromolecular permeability in po dosed golden hamster cheek pouch administered for 10 days,Other,19410467.0,
452,429185,8,1,,103166767,14985,Unspecified,,,78.0,ED50,Antioxidant activity assessed as radical DPPH scavenging activity,Confirmatory,19596200.0,
453,434955,1,2,,47193687,14985,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
454,434962,1,2,,47193687,14985,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
455,434973,1,3,,47193687,14985,Inactive,120538355.0,57337.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7),Screening,,
456,434989,1,1,,47193687,14985,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
457,435003,1,3,,47193687,14985,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
458,435005,1,1,,47193687,14985,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.,Screening,,
459,435022,2,2,,47193687,14985,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
460,435030,1,2,,47193687,14985,Inactive,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
461,435030,1,2,,47193687,14985,Inactive,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
462,437941,7,2,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar rat brain assessed as inhibition of lipid peroxidation,Other,19853328.0,
463,437942,7,2,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar rat brain assessed as reduction in glutathione content,Other,19853328.0,
464,437943,7,2,,103166767,14985,Unspecified,,,,,Inhibition of superoxide dismutase in Wistar rat brain,Other,19853328.0,
465,437944,7,7,,103166767,14985,Unspecified,115707.0,24248.0,,,Inhibition of catalase in Wistar rat brain,Other,19853328.0,
466,437949,8,1,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar rat brain assessed as superoxide dismutase content,Other,19853328.0,
467,437950,8,1,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar rat brain assessed as catalase content,Other,19853328.0,
468,437951,8,1,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar rat brain assessed as lipid peroxidation,Other,19853328.0,
469,437952,8,1,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar rat brain assessed as glutathione content,Other,19853328.0,
470,443182,3,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition of microsomal lipid peroxidation at 100 ug/mL,Other,19962217.0,
471,443183,3,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition of microsomal lipid peroxidation at 200 ug/mL,Other,19962217.0,
472,449728,1,2,,47193687,14985,Inactive,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
473,449739,1,2,,47193687,14985,Inactive,53832009.0,8912.0,,,Inhibitors of Cav3 T-type Calcium Channels: Primary Screen,Screening,,
474,449762,1,2,,47193687,14985,Inactive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
475,449763,1,3,,47193687,14985,Inactive,,,,,uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
476,449768,1,1,,47193687,14985,Inactive,7108463.0,6531.0,,,High Throughput Screening for Cocaine Antagonists: Primary Screen,Screening,,
477,450085,6,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity,Other,19683932.0,
478,450086,6,2,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as ABTS radical scavenging activity,Other,19683932.0,
479,450088,6,2,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as superoxide anion scavenging activity by NBT reduction assay,Other,19683932.0,
480,450089,6,2,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as hydrogen peroxide radical scavenging activity,Other,19683932.0,
481,454509,3,3,,103166767,14985,Unspecified,,,,,Displacement of NBD-Toc from human recombinant alphaTTP at 1 to 2 uM,Other,19897374.0,
482,454510,8,1,,103166767,14985,Active,,,2.42,Kd,Displacement of NBD-Toc from human recombinant alphaTTP,Confirmatory,19897374.0,
483,454511,3,3,,103166767,14985,Unspecified,,,,,Displacement of NBD-Toc from human recombinant alphaTTP at 10 to 15 uM,Other,19897374.0,
484,463079,1,2,,47193687,14985,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
485,463082,1,1,,47193687,14985,Inactive,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
486,463104,1,2,,47193687,14985,Inactive,,,,,uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
487,463111,1,1,,47193687,14985,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4),Screening,,
488,463141,1,2,,47193687,14985,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
489,463165,1,1,,47193687,14985,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of   G-protein signaling 4 (RGS4),Screening,,
490,463190,1,2,,47193687,14985,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
491,463195,1,2,,47193687,14985,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
492,463210,1,2,,47193687,14985,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
493,463212,1,1,,47193687,14985,Inactive,285814664.0,855751.0,,,uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
494,463979,6,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrometric assay method,Other,20034709.0,
495,464263,7,1,,103166767,14985,Active,,,28.4,ED50,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins,Confirmatory,20121165.0,
496,464438,5,3,,103166767,14985,Active,,,0.2,EC50,Neuroprotective activity against glutamate-mediated oxidative stress-induced cell death in mouse HT22 cells assessed as survival after 24 hrs by MTT assay,Confirmatory,20045220.0,
497,464439,5,2,,103166767,14985,Unspecified,,,153.0,EC50,Antioxidant activity assessed as inhibition of Fe(3+)/ascorbate-induced lipid peroxidation in liposomes after 1 hr by TBARS assay,Confirmatory,20045221.0,
498,464440,5,3,,103166767,14985,Unspecified,,,350.0,EC50,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometry,Confirmatory,20045221.0,
499,464441,5,2,,103166767,14985,Unspecified,,,1200.0,EC50,Antioxidant activity assessed as trolox equivalent of ABTS free radical scavenging activity after 6 mins by TRAP assay,Confirmatory,20045221.0,
500,464442,5,2,,103166767,14985,Unspecified,,,1950.0,EC50,Antioxidant activity assessed as reduction of F3+/ferricyanide complex after 20 mins by spectrophotometry,Confirmatory,20045221.0,
501,465638,6,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 10 mins,Other,20058934.0,
502,466205,7,2,,103166767,14985,Unspecified,,,50.0,IC50,Antioxidant activity assessed as DPPH radical scavenging activity after 1 hr,Confirmatory,20146504.0,
503,478241,6,2,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar albino rat assessed as inhibition of catalase activity,Other,20122766.0,
504,478242,6,2,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar albino rat assessed as inhibition of lipid peroxidation,Other,20122766.0,
505,478243,6,2,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar albino rat assessed as reduced glutathione activity,Other,20122766.0,
506,478244,6,2,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar albino rat assessed as inhibition of superoxide dismutase activity,Other,20122766.0,
507,478245,5,1,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar albino rat assessed as lipid peroxidation level,Other,20122766.0,
508,478246,5,1,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar albino rat assessed as reduced glutathione level,Other,20122766.0,
509,478247,5,1,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar albino rat assessed as superoxide dismutase level,Other,20122766.0,
510,478248,5,1,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar albino rat assessed as catalase level,Other,20122766.0,
511,481290,3,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition microsomal lipid peroxidation assessed as malondialdehyde formation at 20 ug/ml by thiobarbituric acid test,Other,20399654.0,
512,485270,1,1,,47193687,14985,Inactive,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
513,485272,1,1,,47193687,14985,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
514,485273,2,1,,47193687,14985,Inactive,4507793.0,7334.0,,,uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay,Screening,,
515,485275,1,3,,47193687,14985,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
516,485281,1,1,,29215204,14985,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
517,485281,1,1,,29215205,14985,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
518,485290,1,1,,26754431,14985,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
519,485290,1,1,,29215204,14985,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
520,485290,1,1,,29215205,14985,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
521,485317,1,2,,47193687,14985,Inactive,54112432.0,2671.0,,,HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS,Screening,,
522,485346,1,1,,47193687,14985,Inactive,88702791.0,4194.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
523,485346,1,1,,47193687,14985,Inactive,89993689.0,4193.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
524,488839,1,1,,47193687,14985,Inactive,20072248.0,8851.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
525,488839,1,1,,47193687,14985,Inactive,48146199.0,1020.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
526,488847,1,3,,47193687,14985,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
527,488862,1,1,,47193687,14985,Inactive,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
528,488890,1,2,,47193687,14985,Inactive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
529,488895,1,2,,47193687,14985,Inactive,90111653.0,948321.0,,,High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
530,488896,1,1,,47193687,14985,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
531,488899,1,1,,47193687,14985,Inactive,40807040.0,4286.0,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
532,488922,1,2,,47193687,14985,Inactive,7706135.0,,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9,Screening,,
533,488965,1,2,,47193687,14985,Inactive,218891639.0,,,,Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
534,488966,1,1,,47193687,14985,Inactive,,,,IC50,Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis,Confirmatory,,
535,488975,1,2,,47193687,14985,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
536,488977,1,2,,47193687,14985,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
537,489030,2,1,,47193687,14985,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
538,489031,2,1,,47193687,14985,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of activators of Apaf-1,Screening,,
539,489932,3,4,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition non-enzymatic reactants generated hydroxyl radical production at 100 ug/ml by spectrophotometry,Other,20542691.0,
540,492140,3,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay,Other,20565070.0,
541,492953,1,1,,47193687,14985,Inactive,296080766.0,5049.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2)",Screening,,
542,492956,1,1,,47193687,14985,Inactive,4758878.0,5051.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2),Screening,,
543,492961,1,1,,29215204,14985,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation,Confirmatory,,
544,492972,1,1,,47193687,14985,Inactive,225543099.0,5050.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3)",Screening,,
545,493005,1,1,,47193687,14985,Inactive,5454140.0,7251.0,,Potency,qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
546,493008,1,1,,47193687,14985,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
547,493008,1,1,,47193687,14985,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
548,493008,1,1,,47193687,14985,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
549,493008,1,1,,47193687,14985,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
550,493011,1,1,,47193687,14985,Inactive,21955158.0,200315.0,,,uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
551,493012,1,1,,47193687,14985,Inactive,13399304.0,60489.0,,,uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
552,493036,1,2,,47193687,14985,Inactive,110611243.0,4923.0,,,Image-Based HTS for Selective Agonists for NTR1,Screening,,
553,493087,1,1,,47193687,14985,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE),Screening,,
554,493091,1,1,,47193687,14985,Inactive,10864009.0,58190.0,,,uHTS Colorimetric assay for identification of inhibitors of Scp-1,Screening,,
555,493098,1,1,,47193687,14985,Inactive,37187860.0,1235.0,,,uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay,Screening,,
556,493131,1,1,,47193687,14985,Inactive,6679827.0,14282.0,,,Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity,Screening,,
557,493160,1,1,,47193687,14985,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing  I (HKDC1),Screening,,
558,493187,1,2,,47193687,14985,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of activators of hexokinase domain containing  I (HKDC1),Screening,,
559,493244,1,1,,47193687,14985,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
560,493244,1,1,,47193687,14985,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
561,493244,1,1,,47193687,14985,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
562,493244,1,1,,47193687,14985,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
563,494206,4,3,,103166767,14985,Active,,,8.2,IC50,Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins,Confirmatory,20452101.0,
564,500081,2,4,,103166767,14985,Active,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins,Other,20684529.0,
565,504326,1,2,,47193687,14985,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
566,504326,1,2,,47193687,14985,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
567,504327,1,1,,26754431,14985,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
568,504327,1,1,,29215204,14985,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
569,504327,1,1,,29215205,14985,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
570,504329,1,1,,47193687,14985,Inactive,227977143.0,23308111.0,,IC50,Discovery of Small Molecule Probes for H1N1 Influenza NS1A,Confirmatory,,
571,504332,1,1,,29215204,14985,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
572,504339,1,1,,47193687,14985,Inactive,162330054.0,,,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
573,504357,1,1,,47193687,14985,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
574,504357,1,1,,47193687,14985,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
575,504406,1,1,,47193687,14985,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
576,504408,2,1,,47193687,14985,Inactive,,,,,Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity,Screening,,
577,504411,1,1,,47193687,14985,Inactive,218931251.0,221955.0,,,"Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB)",Screening,,
578,504414,1,1,,47193687,14985,Inactive,9966877.0,57120.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
579,504414,1,1,,47193687,14985,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
580,504423,1,1,,47193687,14985,Inactive,312275222.0,,,,C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
581,504441,1,1,,47193687,14985,Inactive,6978787.0,25255.0,,,Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
582,504444,1,1,,47193687,14985,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
583,504454,1,3,,47193687,14985,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method,Screening,,
584,504462,1,1,,47193687,14985,Inactive,47132611.0,23192.0,,,uHTS fluorescent assay for identification of inhibitors of ATG4B,Screening,,
585,504490,1,2,,47193687,14985,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling,Screening,,
586,504523,1,1,,47193687,14985,Inactive,45269145.0,9817.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
587,504523,1,1,,47193687,14985,Inactive,224028257.0,4780.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
588,504558,1,1,,47193687,14985,Inactive,23893668.0,3783750.0,,,Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
589,504577,2,2,,47193687,14985,Inactive,6325022.0,855842.0,,,HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
590,504582,2,1,,47193687,14985,Inactive,124809271.0,811941.0,,,In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
591,504621,1,1,,47193687,14985,Inactive,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
592,504634,1,1,,47193687,14985,Inactive,13236497.0,3361.0,,,Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
593,504648,1,1,,47193687,14985,Inactive,,,,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
594,504690,1,3,,47193687,14985,Inactive,12381848.0,,,,uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Screening,,
595,504692,2,2,,47193687,14985,Inactive,13236497.0,3361.0,,,Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
596,504700,1,1,,47193687,14985,Inactive,46909587.0,5567.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
597,504700,1,1,,47193687,14985,Inactive,47132585.0,5577.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
598,504707,1,1,,47193687,14985,Inactive,6755076.0,18749.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
599,504707,1,1,,47193687,14985,Inactive,115496662.0,615074.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
600,504720,1,1,,47193687,14985,Inactive,16130689.0,947252.0,,,uHTS identification of MazEF TA System activators  via a fluorescence-based single-stranded RNase assay,Screening,,
601,504734,1,1,,47193687,14985,Inactive,194068499.0,54106.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding.,Screening,,
602,504749,1,3,,29215204,14985,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
603,504749,1,3,1.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
604,504749,1,3,2.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
605,504749,1,3,3.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
606,504749,1,3,4.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
607,504749,1,3,5.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
608,504749,1,3,6.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
609,504749,1,3,7.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
610,504749,1,3,8.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
611,504749,1,3,9.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
612,504749,1,3,10.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
613,504749,1,3,11.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
614,504749,1,3,12.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
615,504749,1,3,13.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
616,504749,1,3,14.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
617,504749,1,3,15.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
618,504749,1,3,16.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
619,504749,1,3,17.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
620,504749,1,3,18.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
621,504749,1,3,19.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
622,504749,1,3,20.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
623,504749,1,3,21.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
624,504749,1,3,22.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
625,504749,1,3,23.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
626,504749,1,3,24.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
627,504749,1,3,25.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
628,504749,1,3,26.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
629,504749,1,3,27.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
630,504749,1,3,28.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
631,504749,1,3,29.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
632,504749,1,3,30.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
633,504749,1,3,31.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
634,504749,1,3,32.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
635,504749,1,3,33.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
636,504749,1,3,34.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
637,504749,1,3,35.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
638,504749,1,3,36.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
639,504749,1,3,37.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
640,504749,1,3,38.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
641,504749,1,3,39.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
642,504749,1,3,40.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
643,504749,1,3,41.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
644,504749,1,3,42.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
645,504749,1,3,43.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
646,504749,1,3,44.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
647,504749,1,3,45.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
648,504749,1,3,46.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
649,504749,1,3,47.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
650,504749,1,3,48.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
651,504749,1,3,49.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
652,504749,1,3,50.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
653,504749,1,3,51.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
654,504749,1,3,52.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
655,504749,1,3,53.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
656,504749,1,3,54.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
657,504749,1,3,55.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
658,504749,1,3,56.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
659,504749,1,3,57.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
660,504749,1,3,58.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
661,504749,1,3,59.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
662,504749,1,3,60.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
663,504749,1,3,61.0,29215204,14985,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
664,504766,2,1,,47193687,14985,Inactive,5016090.0,190.0,,,"Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1)",Screening,,
665,504775,1,1,,47193687,14985,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity,Screening,,
666,504803,1,1,,47193687,14985,Inactive,121945198.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1),Screening,,
667,504832,1,1,,29215204,14985,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
668,504834,1,1,,29215204,14985,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
669,504845,1,1,,26754431,14985,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
670,504845,1,1,,47193687,14985,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
671,504847,1,1,,26754431,14985,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
672,504847,1,1,,29215204,14985,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
673,504847,1,1,,29215205,14985,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
674,504847,1,1,,47193687,14985,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
675,504865,1,1,,26754431,14985,Inconclusive,118600387.0,7398.0,3.9811,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
676,504865,1,1,,29215204,14985,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
677,504884,1,2,,47193687,14985,Inactive,115347926.0,1175052.0,,,Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
678,504891,1,1,,47193687,14985,Inactive,5453898.0,5300.0,,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
679,504894,1,1,,47193687,14985,Inactive,553160.0,,,Potency,Activators of T cell receptors: qHTS campaign,Confirmatory,,
680,504937,1,2,,47193687,14985,Inactive,179095.0,6609.0,,Potency,Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS,Confirmatory,,
681,527350,1,4,,103166767,14985,Unspecified,,,,,Antioxidant activity against diethyl maleate-induced intracellular ROS accumulation in human CEM cells at 5 uM pretreated for 1 hr before diethyl maleate challenge measured after 30 mins by flow cytometry,Other,20884213.0,
682,540253,1,1,,47193687,14985,Inactive,5031833.0,10073.0,1.4581,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
683,540253,1,1,,47193687,14985,Inactive,5453555.0,5901.0,1.4581,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
684,540253,1,1,,47193687,14985,Inactive,19923142.0,3837.0,1.4581,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
685,540263,1,1,,47193687,14985,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
686,540263,1,1,,47193687,14985,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
687,540267,1,1,,47193687,14985,Inactive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
688,540295,1,1,,47193687,14985,Inactive,119508433.0,4160.0,,,TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R,Screening,,
689,540303,1,1,,47193687,14985,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
690,540303,1,1,,47193687,14985,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
691,540303,1,1,,47193687,14985,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
692,540308,1,1,,47193687,14985,Inactive,119508433.0,4160.0,,,Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R,Screening,,
693,540317,1,1,,47193687,14985,Inactive,187960037.0,10951.0,,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
694,540336,1,1,,47193687,14985,Inactive,68474550.0,3639678.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
695,540336,1,1,,47193687,14985,Inactive,68488893.0,3646682.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
696,540364,1,2,,47193687,14985,Inactive,,2395.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter,Screening,,
697,588211,2,3,,103166767,14985,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",Other,20014752.0,
698,588212,2,3,,103166767,14985,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",Other,20014752.0,
699,588213,2,3,,103166767,14985,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",Other,20014752.0,
700,588334,1,1,,47193687,14985,Inactive,,,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity,Screening,,
701,588335,1,1,,47193687,14985,Inactive,,,,,Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts,Screening,,
702,588352,1,2,,47193687,14985,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
703,588354,1,1,,47193687,14985,Inactive,22538455.0,8648.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1),Screening,,
704,588358,1,2,,47193687,14985,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies,Screening,,
705,588379,1,2,,26754431,14985,Inactive,13399304.0,60489.0,,Potency,qHTS for inhibitors of Vif-A3G interactions: Validation,Confirmatory,,
706,588391,1,1,,47193687,14985,Inactive,14790033.0,5034.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
707,588405,1,1,,47193687,14985,Inactive,78486550.0,171071.0,,,HTS Assay for Peg3 Promoter Inhibitors,Screening,,
708,588413,1,2,,47193687,14985,Inactive,6009644.0,14632.0,,,uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay,Screening,,
709,588436,1,1,,47193687,14985,Inactive,,,,,"Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity",Screening,,
710,588453,1,1,,47193687,14985,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
711,588456,1,1,,47193687,14985,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
712,588458,1,1,,47193687,14985,Inactive,4503351.0,1786.0,,,uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay,Screening,,
713,588473,1,1,,47193687,14985,Inactive,30219.0,1393.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
714,588473,1,1,,47193687,14985,Inactive,38349113.0,1395.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
715,588475,1,2,,47193687,14985,Inactive,30219.0,1393.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
716,588475,1,2,,47193687,14985,Inactive,38349113.0,1395.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
717,588478,1,2,,124799774,14985,Inactive,4877999.0,51377.0,,,"A screen for small molecule inhibitors of the human deubiquitinating enzyme, UCH37",Other,,
718,588489,1,1,,47193687,14985,Inactive,46367787.0,26986.0,,,uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay,Screening,,
719,588492,1,1,,47193687,14985,Inactive,,,,,uHTS identification of small molecule modulators of myocardial damage,Screening,,
720,588493,1,2,,47193687,14985,Inactive,16306916.0,10213.0,,,uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay,Screening,,
721,588497,1,2,,47193687,14985,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,16604538.0,
722,588497,1,2,,47193687,14985,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20035615.0,
723,588497,1,2,,47193687,14985,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20938917.0,
724,588499,1,3,,47193687,14985,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,16604538.0,
725,588499,1,3,,47193687,14985,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20035615.0,
726,588499,1,3,,47193687,14985,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20938917.0,
727,588501,1,2,,47193687,14985,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,16604538.0,
728,588501,1,2,,47193687,14985,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20035615.0,
729,588501,1,2,,47193687,14985,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20938917.0,
730,588511,1,2,,47193687,14985,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
731,588549,1,1,,47193687,14985,Inactive,1781172.0,,,,Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
732,588579,1,1,,26754431,14985,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
733,588579,1,1,,29215204,14985,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
734,588579,1,1,,29215205,14985,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
735,588579,1,1,,47193687,14985,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
736,588590,1,1,,47193687,14985,Inactive,154350220.0,11201.0,,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
737,588591,1,1,,47193687,14985,Inactive,5729982.0,5429.0,,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
738,588621,1,1,,47193687,14985,Inactive,90652859.0,84867.0,,,uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay,Screening,,
739,588627,1,1,,47193687,14985,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
740,588664,1,2,,47193687,14985,Inactive,62362414.0,25.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
741,588664,1,2,,47193687,14985,Inactive,68989256.0,9610.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
742,588674,1,2,,47193687,14985,Inactive,,,,,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
743,588675,1,1,,47193687,14985,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
744,588676,1,1,,47193687,14985,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
745,588689,1,1,,47193687,14985,Inactive,219689243.0,,,IC50,Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition,Confirmatory,,
746,588692,2,1,,47193687,14985,Inactive,,,,,Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
747,588726,1,2,,47193687,14985,Inactive,15607504.0,886474.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis,Screening,,
748,588727,1,1,,47193687,14985,Inactive,,,,IC50,"A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83",Confirmatory,,
749,588795,1,1,,47193687,14985,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
750,588814,1,3,,47193687,14985,Inactive,37622910.0,1128.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1)",Screening,,
751,588819,1,4,,47193687,14985,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1).,Screening,,
752,588850,1,1,,47193687,14985,Inactive,90421313.0,1080.0,,,uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay,Screening,,
753,588852,1,3,,47193687,14985,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1),Screening,,
754,588855,1,1,,47193687,14985,Inactive,18418623.0,4088.0,,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
755,588856,1,1,,47193687,14985,Inactive,,,,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
756,589056,1,10,,103166767,14985,Unspecified,116241312.0,1576.0,,,"Clinically relevant inducers of human liver microsomal P450 enzymes, isoform CYP3A4",Other,,
757,590703,3,2,,103166767,14985,Unspecified,,,77.2,IC50,Antioxidant activity assessed as ABTS radical scavenging activity,Confirmatory,21345544.0,
758,598648,1,5,,103166767,14985,Inconclusive,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 10 ug/ml by UV-visible spectrophotometry,Other,21612921.0,
759,598649,1,4,,103166767,14985,Unspecified,,,,,Anti-lipid peroxidation activity ferric chloride-induced lipid peroxidation using egg yolk homogenate at 40 ug/ml by TBARS assay,Other,21612921.0,
760,599477,1,4,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 0.2 mM after 20 mins by UV spectrophotometry,Other,19428246.0,
761,602123,1,1,,47193687,14985,Inactive,16128424.0,945085.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon),Screening,,
762,602141,1,1,,47193687,14985,Inactive,,,,,uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors,Screening,,
763,602162,1,1,,47193687,14985,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set,Screening,,
764,602163,1,1,,47193687,14985,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA),Screening,,
765,602179,1,2,,47193687,14985,Inactive,89573979.0,3417.0,,Potency,qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS,Confirmatory,,
766,602229,1,1,,47193687,14985,Inactive,216409728.0,10002.0,,,"Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
767,602233,1,1,,47193687,14985,Inactive,115503961.0,4357161.0,,Potency,qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
768,602244,1,2,,47193687,14985,Inactive,5730106.0,10663.0,,,uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay,Screening,,
769,602247,1,2,,47193687,14985,Inactive,,,,,Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
770,602248,1,2,,47193687,14985,Inactive,,,,,Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
771,602250,1,2,,47193687,14985,Inactive,,,,,Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line,Screening,,
772,602252,1,1,,47193687,14985,Inactive,62868213.0,57120.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
773,602252,1,1,,47193687,14985,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
774,602261,1,1,,47193687,14985,Inactive,41872631.0,2194.0,,,uHTS identification of small molecule inhibitors of  the thioesterase domain of fatty acid synthase via a fluorescence intensity assay,Screening,,
775,602274,1,2,,47193687,14985,Inactive,,,,,uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells,Screening,,
776,602281,1,1,,47193687,14985,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
777,602281,1,1,,47193687,14985,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
778,602310,1,2,,47193687,14985,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
779,602313,1,1,,47193687,14985,Inactive,22907044.0,200316.0,,Potency,qHTS for Inhibitors of Vif-A3F Interactions: qHTS,Confirmatory,,
780,602329,1,1,,47193687,14985,Inactive,216548193.0,8438.0,,,Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
781,602332,1,1,,26754431,14985,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
782,602332,1,1,,29215204,14985,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
783,602332,1,1,,29215205,14985,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
784,602332,1,1,,47193687,14985,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
785,602340,1,2,,47193687,14985,Inactive,,,,,HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity,Screening,,
786,602342,2,1,,47193687,14985,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
787,602346,1,1,,47193687,14985,Inactive,9629361.0,155459.0,,,Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
788,602363,1,1,,47193687,14985,Inactive,,,,,Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity,Screening,,
789,602393,1,1,,47193687,14985,Inactive,291463269.0,20586.0,,,Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
790,602396,1,2,,47193687,14985,Inactive,4504343.0,2494.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2),Screening,,
791,602399,1,2,,47193687,14985,Inactive,15927174.0,,,,uHTS identification of inhibitors of NadD in a Colorimetric assay,Screening,,
792,602405,1,1,,47193687,14985,Inactive,75495260.0,,,,PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
793,602410,1,1,,47193687,14985,Inactive,11093520.0,3777.0,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3,Screening,,
794,602429,1,1,,47193687,14985,Inactive,1762973.0,7341.0,,,uHTS identification of SUMO1-mediated protein-protein interactions,Screening,,
795,602438,1,1,,47193687,14985,Inactive,160877737.0,,,,uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay,Screening,,
796,602440,1,1,,47193687,14985,Inactive,262118306.0,123228.0,,,uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8),Screening,,
797,602449,1,2,,47193687,14985,Inactive,,,,,uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay,Screening,,
798,602481,1,1,,47193687,14985,Inactive,378544807.0,,,,Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
799,603957,1,3,,103166767,14985,Unspecified,,,,,"Octanol-water partition coefficient, log P of the compound",Other,17629592.0,
800,607705,1,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition microsomal lipid peroxidation at 100 ug/ml by thiobarbituric acid test,Other,21723119.0,
801,623870,1,1,,47193687,14985,Inactive,2702319.0,405.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
802,623870,1,1,,47193687,14985,Inactive,5454102.0,10460.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
803,623877,1,1,,47193687,14985,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A),Screening,,
804,623901,1,1,,47193687,14985,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity,Screening,,
805,624030,1,2,,29215204,14985,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
806,624031,1,2,,29215204,14985,Inactive,,,,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
807,624032,1,2,,29215204,14985,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
808,624037,1,3,,47193687,14985,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
809,624038,1,3,,47193687,14985,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
810,624040,1,3,,47193687,14985,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
811,624044,1,2,,29215204,14985,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
812,624125,1,4,,47193687,14985,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
813,624126,1,3,,47193687,14985,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
814,624127,1,2,,47193687,14985,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
815,624168,1,1,,47193687,14985,Inactive,47678551.0,9215.0,,,uHTS identification of small molecule activators of alpha dystroglycan glycosylation,Screening,,
816,624169,1,1,,47193687,14985,Inactive,27753985.0,15558.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A),Screening,,
817,624170,1,1,,29215204,14985,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
818,624170,1,1,,47193687,14985,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
819,624171,1,1,,47193687,14985,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators,Confirmatory,,
820,624172,1,1,,29215204,14985,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
821,624172,1,1,,47193687,14985,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
822,624173,1,3,,29215204,14985,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
823,624173,1,3,,47193687,14985,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
824,624178,1,1,,47193687,14985,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
825,624202,1,1,,47193687,14985,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
826,624204,1,2,,47193687,14985,Inactive,7657550.0,,,,"uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay",Screening,,
827,624246,1,1,,47193687,14985,Inactive,343478176.0,2078.0,,Potency,qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction,Confirmatory,,
828,624256,1,2,,47193687,14985,Inactive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with MLPCN compound set,Screening,,
829,624263,1,1,,47193687,14985,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
830,624263,1,1,,47193687,14985,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
831,624267,1,2,,47193687,14985,Inactive,4506537.0,8767.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
832,624267,1,2,,47193687,14985,Inactive,119603173.0,64127.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
833,624268,1,3,,47193687,14985,Inactive,71746704.0,3662741.0,,,Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS),Screening,,
834,624288,1,1,,47193687,14985,Inactive,52000961.0,2778.0,,Potency,"qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
835,624296,1,1,,29215204,14985,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
836,624296,1,1,,47193687,14985,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
837,624297,1,1,,29215204,14985,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
838,624297,1,1,,47193687,14985,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
839,624304,1,2,,47193687,14985,Inactive,25148072.0,177343.0,,,uHTS identification of SKN-1 Inhibitors in a fluoresence assay,Screening,,
840,624330,1,2,,47193687,14985,Inactive,21361397.0,29127.0,,IC50,Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP -  Primary and Confirmatory Screens,Confirmatory,,
841,624349,1,2,,121362965,14985,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
842,624352,1,1,,47193687,14985,Inactive,40254439.0,2034.0,,,uHTS identification of HIF-2a Inhibitors in a luminesence assay,Screening,,
843,624354,1,1,,47193687,14985,Inactive,224494019.0,8795.0,,,uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay,Screening,,
844,624377,1,1,,47193687,14985,Inactive,351542238.0,50807.0,,,"Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1)",Screening,,
845,624414,1,1,,47193687,14985,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
846,624415,1,2,,47193687,14985,Inactive,10092597.0,57192.0,,,qHTS for Inhibitors of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
847,624416,1,1,,47193687,14985,Inactive,9629363.0,155971.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9",Screening,,
848,624417,1,1,,47193687,14985,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode),Confirmatory,,
849,624418,1,1,,47193687,14985,Inactive,,,,Potency,qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen,Confirmatory,,
850,624463,1,1,,47193687,14985,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists,Other,,
851,624464,1,1,,47193687,14985,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators,Other,,
852,624465,1,1,,47193687,14985,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists,Other,,
853,624466,1,3,,47193687,14985,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
854,624467,1,1,,47193687,14985,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
855,624483,1,1,,47193687,14985,Inactive,,,,,Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease,Screening,,
856,624619,3,2,,103166767,14985,Unspecified,136727.0,7364.0,,,Specific activity of expressed human recombinant UGT2B7,Other,10836148.0,
857,625144,5,5,,103166767,14985,Unspecified,239977155.0,,,IC50,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),Confirmatory,,
858,625145,4,7,,103166767,14985,Unspecified,20138087.0,10800.0,,IC50,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),Confirmatory,,
859,625146,5,5,,103166767,14985,Unspecified,126397.0,100009114.0,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),Confirmatory,,
860,625147,4,7,,103166767,14985,Unspecified,395398606.0,4159.0,,IC50,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
861,625148,4,7,,103166767,14985,Unspecified,60392672.0,4160.0,,IC50,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
862,625149,4,7,,103166767,14985,Unspecified,729996.0,4161.0,,IC50,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
863,625150,5,5,,103166767,14985,Unspecified,113978.0,4128.0,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),Confirmatory,,
864,625151,4,7,,103166767,14985,Unspecified,113118.0,1128.0,,IC50,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
865,625152,4,7,,103166767,14985,Unspecified,113122.0,1129.0,,IC50,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
866,625153,4,7,,103166767,14985,Unspecified,113125.0,1131.0,,IC50,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
867,625154,4,7,,103166767,14985,Unspecified,23503039.0,1132.0,,IC50,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
868,625155,4,7,,103166767,14985,Unspecified,543761.0,1133.0,,IC50,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
869,625156,1,9,,103166767,14985,Unspecified,128997.0,4886.0,,,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),Other,,
870,625157,6,2,,103166767,14985,Unspecified,1352610.0,4887.0,,IC50,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),Confirmatory,,
871,625158,3,4,,103166767,14985,Unspecified,,,,IC50,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),Confirmatory,,
872,625159,5,5,,103166767,14985,Unspecified,266646.0,24598.0,,IC50,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",Confirmatory,,
873,625160,1,9,,103166767,14985,Unspecified,266649.0,18126.0,,,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",Other,,
874,625161,4,7,,103166767,14985,Unspecified,311033488.0,4985.0,,IC50,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",Confirmatory,,
875,625162,4,7,,103166767,14985,Unspecified,116242691.0,4986.0,,IC50,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",Confirmatory,,
876,625163,4,7,,103166767,14985,Unspecified,2851402.0,4988.0,,IC50,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",Confirmatory,,
877,625164,1,6,,103166767,14985,Unspecified,,,,,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),Other,,
878,625165,3,4,,103166767,14985,Unspecified,,,,IC50,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),Confirmatory,,
879,625166,3,4,,103166767,14985,Unspecified,,,,IC50,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),Confirmatory,,
880,625167,5,5,,103166767,14985,Unspecified,317373261.0,8654.0,,IC50,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),Confirmatory,,
881,625168,4,7,,103166767,14985,Unspecified,129557.0,5724.0,,IC50,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),Confirmatory,,
882,625169,1,6,,103166767,14985,Unspecified,,,,,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),Other,,
883,625170,3,4,,103166767,14985,Unspecified,,,,IC50,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),Confirmatory,,
884,625171,4,7,,103166767,14985,Unspecified,7531135.0,3757.0,,IC50,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),Confirmatory,,
885,625172,4,7,,103166767,14985,Unspecified,75071465.0,,,IC50,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),Confirmatory,,
886,625173,5,5,,103166767,14985,Unspecified,2822103.0,100009274.0,,IC50,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",Confirmatory,,
887,625174,5,5,,103166767,14985,Unspecified,266321.0,834.0,,IC50,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",Confirmatory,,
888,625175,5,5,,103166767,14985,Unspecified,115725.0,1511.0,,IC50,"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)",Confirmatory,,
889,625176,1,9,,103166767,14985,Unspecified,119292.0,1991.0,,,"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)",Other,,
890,625177,5,5,,103166767,14985,Unspecified,116852.0,4312.0,,IC50,"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",Confirmatory,,
891,625178,5,5,,103166767,14985,Unspecified,269849668.0,4318.0,,IC50,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",Confirmatory,,
892,625179,1,9,,103166767,14985,Unspecified,317373571.0,5578.0,,,DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone),Other,,
893,625180,5,5,,103166767,14985,Unspecified,232066.0,5595.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
894,625181,5,5,,103166767,14985,Unspecified,119554.0,5594.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
895,625182,5,5,,103166767,14985,Unspecified,2499600.0,1432.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
896,625183,5,5,,103166767,14985,Unspecified,1352673.0,5530.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)",Confirmatory,,
897,625184,5,5,,103166767,14985,Unspecified,2811086.0,1956.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
898,625185,5,5,,103166767,14985,Unspecified,125370.0,2534.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
899,625186,5,5,,103166767,14985,Unspecified,119533.0,2064.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
900,625187,5,5,,103166767,14985,Unspecified,125474.0,3932.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
901,625188,1,9,,103166767,14985,Unspecified,33112650.0,5788.0,,,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",Other,,
902,625189,1,7,,103166767,14985,Unspecified,,,,,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",Other,,
903,625190,4,5,,103166767,14985,Unspecified,,,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),Confirmatory,,
904,625191,4,7,,103166767,14985,Unspecified,112815.0,25075.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
905,625192,4,7,,103166767,14985,Unspecified,543727.0,3356.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),Confirmatory,,
906,625193,5,5,,103166767,14985,Unspecified,113037.0,43.0,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),Confirmatory,,
907,625194,4,7,,103166767,14985,Unspecified,231473.0,134.0,,IC50,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),Confirmatory,,
908,625195,4,7,,103166767,14985,Unspecified,543740.0,135.0,,IC50,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),Confirmatory,,
909,625196,5,6,,103166767,14985,Unspecified,803374855.0,140.0,,IC50,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),Confirmatory,,
910,625197,3,4,,103166767,14985,Unspecified,,,,IC50,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),Confirmatory,,
911,625198,4,7,,103166767,14985,Unspecified,1168247.0,29412.0,,IC50,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
912,625199,4,7,,103166767,14985,Unspecified,543734.0,24173.0,,IC50,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
913,625200,4,7,,103166767,14985,Unspecified,1168243.0,146.0,,IC50,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
914,625201,4,7,,103166767,14985,Unspecified,1351829.0,150.0,,IC50,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Confirmatory,,
915,625202,4,7,,103166767,14985,Unspecified,613504690.0,151.0,,IC50,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),Confirmatory,,
916,625203,4,7,,103166767,14985,Unspecified,20141211.0,152.0,,IC50,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),Confirmatory,,
917,625204,4,7,,103166767,14985,Unspecified,48429211.0,153.0,,IC50,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
918,625205,4,7,,103166767,14985,Unspecified,296439450.0,154.0,,IC50,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),Confirmatory,,
919,625206,4,7,,103166767,14985,Unspecified,461604.0,155.0,,IC50,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
920,625207,4,7,,103166767,14985,Unspecified,128616.0,6530.0,,IC50,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Confirmatory,,
921,625208,5,5,,103166767,14985,Unspecified,1168407.0,24192.0,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),Confirmatory,,
922,625209,4,7,,103166767,14985,Unspecified,1703214.0,186.0,,IC50,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),Confirmatory,,
923,625210,3,4,,103166767,14985,Unspecified,,,,IC50,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",Confirmatory,,
924,625211,1,6,,103166767,14985,Unspecified,,,,,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),Other,,
925,625212,3,4,,103166767,14985,Unspecified,,,,IC50,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),Confirmatory,,
926,625213,4,7,,103166767,14985,Unspecified,2506481.0,624.0,,IC50,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),Confirmatory,,
927,625214,1,9,,103166767,14985,Unspecified,550544247.0,799.0,,,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),Other,,
928,625215,3,4,,103166767,14985,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",Confirmatory,,
929,625216,3,4,,103166767,14985,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",Confirmatory,,
930,625217,4,7,,103166767,14985,Unspecified,1168220.0,3357.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),Confirmatory,,
931,625218,4,7,,103166767,14985,Unspecified,112816.0,3358.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),Confirmatory,,
932,625219,3,4,,103166767,14985,Unspecified,,,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),Confirmatory,,
933,625220,4,7,,103166767,14985,Unspecified,6224984.0,100135548.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),Confirmatory,,
934,625221,4,7,,103166767,14985,Unspecified,1703010.0,3362.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),Confirmatory,,
935,625222,4,7,,103166767,14985,Unspecified,400630.0,6532.0,,IC50,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",Confirmatory,,
936,625223,4,7,,103166767,14985,Unspecified,74752153.0,10280.0,,IC50,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),Confirmatory,,
937,625224,3,4,,103166767,14985,Unspecified,,,,IC50,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),Confirmatory,,
938,625225,3,4,,103166767,14985,Unspecified,,,,IC50,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",Confirmatory,,
939,625226,4,7,,103166767,14985,Unspecified,128359.0,6869.0,,IC50,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),Confirmatory,,
940,625227,4,7,,103166767,14985,Unspecified,229462950.0,6865.0,,IC50,DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968),Confirmatory,,
941,625228,4,7,,103166767,14985,Unspecified,113832.0,24208.0,,IC50,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),Confirmatory,,
942,625229,5,5,,103166767,14985,Unspecified,254763392.0,6916.0,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),Confirmatory,,
943,625230,1,6,,103166767,14985,Unspecified,,,,,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",Other,,
944,625231,4,7,,103166767,14985,Unspecified,143811474.0,2321.0,,IC50,DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF),Confirmatory,,
945,625232,1,9,,103166767,14985,Unspecified,418253.0,7433.0,,,DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP),Other,,
946,625233,4,7,,103166767,14985,Unspecified,586197.0,552.0,,IC50,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),Confirmatory,,
947,625234,3,4,,103166767,14985,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",Confirmatory,,
948,625235,4,7,,103166767,14985,Unspecified,115562.0,1268.0,,IC50,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),Confirmatory,,
949,625236,5,5,,103166767,14985,Unspecified,115456.0,760.0,,IC50,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),Confirmatory,,
950,625237,4,7,,103166767,14985,Unspecified,1168965.0,729230.0,,IC50,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),Confirmatory,,
951,625238,4,7,,103166767,14985,Unspecified,1705894.0,1233.0,,IC50,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),Confirmatory,,
952,625239,4,7,,103166767,14985,Unspecified,1705896.0,1234.0,,IC50,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),Confirmatory,,
953,625240,1,9,,103166767,14985,Unspecified,108936015.0,3577.0,,,DRUGMATRIX: Chemokine CXCR1 (IL-8A),Other,,
954,625241,4,7,,103166767,14985,Unspecified,1352454.0,3579.0,,IC50,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),Confirmatory,,
955,625242,4,7,,103166767,14985,Unspecified,416772.0,886.0,,IC50,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",Confirmatory,,
956,625243,5,5,,103166767,14985,Unspecified,317373262.0,5742.0,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),Confirmatory,,
957,625244,5,5,,103166767,14985,Unspecified,3915797.0,5743.0,,IC50,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),Confirmatory,,
958,625245,5,5,,103166767,14985,Unspecified,117144.0,1544.0,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
959,625246,1,9,,103166767,14985,Unspecified,308153612.0,1548.0,,,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Other,,
960,625247,5,5,,103166767,14985,Unspecified,60416369.0,1557.0,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
961,625248,5,5,,103166767,14985,Unspecified,6686268.0,1559.0,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
962,625249,5,5,,103166767,14985,Unspecified,84028191.0,1565.0,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
963,625250,5,5,,103166767,14985,Unspecified,117250.0,1571.0,,IC50,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
964,625251,5,5,,103166767,14985,Unspecified,116241312.0,1576.0,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",Confirmatory,,
965,625252,4,7,,103166767,14985,Unspecified,118228.0,1812.0,,IC50,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),Confirmatory,,
966,625253,4,7,,103166767,14985,Unspecified,118206.0,1813.0,,IC50,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
967,625254,4,7,,103166767,14985,Unspecified,1169206.0,1814.0,,IC50,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
968,625255,4,7,,103166767,14985,Unspecified,1345939.0,1815.0,,IC50,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
969,625256,4,7,,103166767,14985,Unspecified,266667.0,6531.0,,IC50,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),Confirmatory,,
970,625257,4,7,,103166767,14985,Unspecified,119606.0,1909.0,,IC50,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),Confirmatory,,
971,625258,4,7,,103166767,14985,Unspecified,544257.0,2099.0,,IC50,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),Confirmatory,,
972,625259,4,7,,103166767,14985,Unspecified,6166154.0,2100.0,,IC50,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),Confirmatory,,
973,625260,3,4,,103166767,14985,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",Confirmatory,,
974,625261,3,4,,103166767,14985,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",Confirmatory,,
975,625262,3,4,,103166767,14985,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",Confirmatory,,
976,625263,4,7,,103166767,14985,Unspecified,121069.0,2908.0,,IC50,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),Confirmatory,,
977,625264,3,4,,103166767,14985,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",Confirmatory,,
978,625265,1,6,,103166767,14985,Unspecified,,,,,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",Other,,
979,625266,3,4,,103166767,14985,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",Confirmatory,,
980,625267,3,4,,103166767,14985,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",Confirmatory,,
981,625268,4,2,,103166767,14985,Unspecified,121579.0,24397.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
982,625268,4,2,,103166767,14985,Unspecified,121580.0,114516.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
983,625268,4,2,,103166767,14985,Unspecified,121604.0,25456.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
984,625268,4,2,,103166767,14985,Unspecified,12230887.0,25674.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
985,625269,4,7,,103166767,14985,Unspecified,547645.0,3269.0,,IC50,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",Confirmatory,,
986,625270,4,7,,103166767,14985,Unspecified,123120.0,3274.0,,IC50,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),Confirmatory,,
987,625271,5,5,,103166767,14985,Unspecified,123343.0,3156.0,,IC50,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),Confirmatory,,
988,625272,3,4,,103166767,14985,Unspecified,,,,IC50,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",Confirmatory,,
989,625273,4,6,,103166767,14985,Unspecified,124531.0,24954.0,,IC50,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),Confirmatory,,
990,625274,1,6,,103166767,14985,Unspecified,,,,,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),Other,,
991,625275,3,4,,103166767,14985,Unspecified,,,,IC50,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",Confirmatory,,
992,626113,1,3,,103166767,14985,Unspecified,,,,,Antioxidant activity against microsomal lipid peroxidation assessed as malondialdehyde formation at 200 mg/ml after 90 mins by thiobarbituric acid method,Other,21930379.0,
993,633940,3,2,,103166767,14985,Active,,,28.0,IC50,Antioxidant activity assessed as DPPH radicle scavenging activity after 30 mins by spectrometric analysis,Confirmatory,22145663.0,
994,640885,3,2,,103166767,14985,Active,,,12.5,IC50,Antioxidant activity assessed as inhibition of lipid peroxidation,Confirmatory,22209460.0,
995,642426,1,4,,103166767,14985,Active,,,0.23399999999999999,EC50,Cytoprotective activity against BSO-induced human FRDA primary patient fibroblasts compound pretreated 12 hrs prior to BSO-induction measured after 48 hrs by calcein-AM-based cell viability assay,Confirmatory,22137789.0,
996,642427,3,2,,103166767,14985,Unspecified,,,300.0,GI50,Growth inhibition of human FRDA primary patient fibroblasts after 48 hrs by calcein-AM-based cell viability assay,Confirmatory,22137789.0,
997,642429,1,4,,103166767,14985,Unspecified,,,,,"Therapeutic index, ratio of LC50 to GI50 for human FRDA primary patient fibroblasts",Other,22137789.0,
998,647574,3,3,,103166767,14985,Active,,,9.0,IC50,Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins,Confirmatory,22233425.0,
999,648929,1,4,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as hydroxyl radical scavenging activity at 2.5 mM by electron spin resonance method,Other,22356736.0,
1000,648931,1,4,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as superoxide radical scavenging activity at 2.5 mM by electron spin resonance method,Other,22356736.0,
1001,650645,3,4,,103166767,14985,Active,,,11.4,IC50,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometry,Confirmatory,22377672.0,
1002,651550,1,1,,47193687,14985,Inactive,60391226.0,207.0,,,HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen,Screening,,
1003,651560,1,1,,47193687,14985,Inactive,1709543.0,52.0,,,"uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay",Screening,,
1004,651572,1,2,,47193687,14985,Inactive,21489979.0,246310.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1),Screening,,
1005,651582,1,1,,47193687,14985,Inactive,,,,,uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay,Screening,,
1006,651602,1,1,,47193687,14985,Inactive,16130723.0,947287.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1007,651602,1,1,,47193687,14985,Inactive,16130724.0,947286.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1008,651602,1,1,,47193687,14985,Inactive,16130726.0,947294.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1009,651631,4,1,,144204114,14985,Inconclusive,269849759.0,7157.0,0.2985,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
1010,651631,4,1,,144206759,14985,Inconclusive,269849759.0,7157.0,21.1317,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
1011,651631,4,1,,144209279,14985,Inconclusive,269849759.0,7157.0,21.8665,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
1012,651632,4,1,,144204114,14985,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
1013,651632,4,1,,144206759,14985,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
1014,651632,4,1,,144209279,14985,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
1015,651633,4,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
1016,651633,4,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
1017,651633,4,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
1018,651634,4,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
1019,651634,4,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
1020,651634,4,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
1021,651635,1,3,,47193687,14985,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
1022,651636,1,1,,47193687,14985,Inactive,4826706.0,1880.0,,,uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay,Screening,,
1023,651640,1,1,,47193687,14985,Inactive,,,,,DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity,Screening,,
1024,651644,1,1,,47193687,14985,Inactive,28872817.0,155807.0,,Potency,qHTS Assay for Inhibitors of the HIV-1 protein Vpr,Confirmatory,,
1025,651647,1,1,,47193687,14985,Inactive,4826834.0,4323.0,,,uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay,Screening,,
1026,651654,1,1,,47193687,14985,Inactive,,,,,HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1027,651661,2,1,,47193687,14985,Inactive,,,,,Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1028,651687,1,1,,47193687,14985,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1029,651699,1,1,,47193687,14985,Inactive,4502169.0,8883.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
1030,651699,1,1,,47193687,14985,Inactive,4507791.0,9040.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
1031,651702,1,2,,47193687,14985,Inactive,,,,,Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library,Screening,,
1032,651718,1,2,,47193687,14985,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA),Screening,,
1033,651723,1,1,,47193687,14985,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Activator_SinglePoint_HTS_Activity,Screening,,
1034,651724,1,1,,47193687,14985,Inactive,1730321.0,5932.0,,,qHTS Assay for Inhibitors of the CtBP/E1A Interaction,Screening,,
1035,651725,1,1,,47193687,14985,Inactive,1246761.0,6495.0,,,qHTS Assay for Inhibitors of the Six1/Eya2 Interaction,Screening,,
1036,651768,1,2,,47193687,14985,Inactive,3719421.0,7486.0,,Potency,qHTS for Inhibitors of WRN Helicase,Confirmatory,,
1037,651800,1,1,,47193687,14985,Inactive,2358024.0,6955.0,,,Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe,Screening,,
1038,651819,1,1,,47193687,14985,Inactive,83758679.0,153562.0,,,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity,Screening,,
1039,651820,1,1,,47193687,14985,Inactive,,,,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
1040,651821,2,4,,47193687,14985,Inactive,,,,,Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats,Screening,,
1041,651957,1,1,,47193687,14985,Inactive,5729858.0,10499.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2),Screening,,
1042,651958,1,1,,47193687,14985,Inactive,76364066.0,2943075.0,,,Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Screening,,
1043,651965,1,1,,47193687,14985,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
1044,651999,1,1,,47193687,14985,Inactive,38027923.0,10987.0,,,"uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay",Screening,,
1045,652010,1,1,,47193687,14985,Inactive,5016090.0,190.0,,,"Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Screening,,
1046,652017,1,1,,47193687,14985,Inactive,119579215.0,6595.0,,,"Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM)",Screening,,
1047,652025,1,1,,47193687,14985,Inactive,7110653.0,16183.0,,Potency,qHTS of IL-2 Activators,Confirmatory,,
1048,652039,1,1,,47193687,14985,Inactive,21327705.0,5650.0,,,Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen,Screening,,
1049,652048,1,2,,47193687,14985,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
1050,652048,1,2,,144204114,14985,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
1051,652051,1,1,,47193687,14985,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
1052,652051,1,1,,144204114,14985,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
1053,652054,1,1,,47193687,14985,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Antagonist: qHTS,Screening,,
1054,652067,1,4,,47193687,14985,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12),Screening,,
1055,652104,1,1,,47193687,14985,Inactive,20140568.0,23435.0,,Potency,qHTS of TDP-43 Inhibitors,Confirmatory,,
1056,652105,1,1,,47193687,14985,Inactive,18266879.0,5305.0,,Potency,qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K),Confirmatory,,
1057,652106,1,1,,47193687,14985,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
1058,652126,1,3,,47193687,14985,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12),Screening,,
1059,652154,1,1,,47193687,14985,Inactive,998701.0,7849.0,,,HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1060,652257,1,1,,47193687,14985,Inactive,32425330.0,3276.0,,,Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1),Screening,,
1061,665149,1,3,,103166767,14985,Active,,,,,Cytoprotective activity against DEM-induced ROS production in human CEM cells treated prior DEM challenge after 16 hrs by DCFH-DA-based flow cytometry relative to alpha-tocopherol,Other,22560834.0,
1062,665150,1,3,,103166767,14985,Active,,,,,Cytoprotective activity against DEM-induced ROS production in human CEM cells assessed as reduction in lipid peroxidation at 2.5 to 5 uM treated prior DEM challenge measured after 16 hrs by C11-BODIPY581/591-based flow cytometry relative to alpha-tocopherol,Other,22560834.0,
1063,665154,1,3,,103166767,14985,Active,,,,,Cytoprotective activity against DEM-induced ROS production in human CEM cells at 1 to 5 uM pretreated for 16 hrs prior DEM challenge measured after 5.5 hrs by trypan blue exclusion method,Other,22560834.0,
1064,671788,1,3,,103166767,14985,Unspecified,,,,,Prodrug conversion in human NHEK cells assessed as dl-alpha-tocopherol level at 10 uM after 24 hrs,Other,22579618.0,
1065,671789,1,3,,103166767,14985,Unspecified,,,,,Prodrug conversion in human NHEK cells assessed as dl-alpha-tocopherol level at 50 uM after 24 hrs,Other,22579618.0,
1066,676962,1,3,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 100 uM by spectrophotometry based TBARS assay relative to untreated control,Other,22858298.0,
1067,676963,1,3,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 3.16 uM by spectrophotometry based TBARS assay relative to untreated control,Other,22858298.0,
1068,676984,1,3,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 0.32 uM by spectrophotometry based TBARS assay relative to untreated control,Other,22858298.0,
1069,676986,1,3,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 1 uM by spectrophotometry based TBARS assay relative to untreated control,Other,22858298.0,
1070,676988,1,3,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 0.1 uM by spectrophotometry based TBARS assay relative to untreated control,Other,22858298.0,
1071,678023,1,3,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 10 uM by spectrophotometry based TBARS assay relative to untreated control,Other,22858298.0,
1072,678024,2,2,,103166767,14985,Active,,,6.78,IC50,Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation by spectrophotometry based TBARS assay,Confirmatory,22858298.0,
1073,678026,1,3,,103166767,14985,Unspecified,,,,,Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 31.62 uM by spectrophotometry based TBARS assay relative to untreated control,Other,22858298.0,
1074,678276,2,3,,103166767,14985,Unspecified,,,59.0,IC50,Antioxidant activity assessed as inhibition of DPPH radical generation,Confirmatory,22884407.0,
1075,678612,1,4,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 10 to 80 uM,Other,22902655.0,
1076,678613,1,5,,103166767,14985,Inconclusive,,,,,Antioxidant activity in Wistar rat liver microsomes assessed as reduction of lipid peroxidase activity by TBA assay,Other,22902655.0,
1077,678614,1,3,,103166767,14985,Inconclusive,,,,,Metal chelating activity of the compound assessed as ratio of Fe2+ concentration to compound concentration,Other,22902655.0,
1078,686940,1,1,,47193687,14985,Inactive,14149746.0,7026.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2),Screening,,
1079,686964,1,1,,47193687,14985,Inactive,21595776.0,8932.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide,Screening,,
1080,686970,1,2,,47193687,14985,Inactive,49168486.0,3417.0,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line,Confirmatory,,
1081,686971,1,2,,47193687,14985,Inactive,,,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,Confirmatory,,
1082,686977,2,1,,49698474,14985,Inactive,9657203.0,2615631.0,,IC50,Vibrio cholerae assay for pro-quorum sensing small molecules,Confirmatory,,
1083,686978,1,1,,26754431,14985,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1084,686978,1,1,,47193687,14985,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1085,686978,1,1,,144204114,14985,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1086,686979,1,1,,26754431,14985,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1087,686979,1,1,,47193687,14985,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1088,686979,1,1,,144204114,14985,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1089,686992,2,1,,47193687,14985,Inactive,187960042.0,6401.0,,,Identification of agents that induce E-selectin on human endothelial cells Measured in Cell-Based System Using Imaging - 2152-01_Activator_SinglePoint_HTS_Activity,Screening,,
1090,687014,1,1,,47193687,14985,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12).,Screening,,
1091,687016,1,1,,47193687,14985,Inactive,115430235.0,29128.0,,,Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide,Screening,,
1092,687694,1,2,,103166767,14985,Unspecified,,,,,Antioxidant activity in microsomes assessed as inhibition of lipid peroxidation by measuring MDA level at 200 ug/ml by spectrophotometry based TBARS method,Other,23078966.0,
1093,690597,1,2,,103166767,14985,Active,,,,,Antioxidant activity assessed as ferric ion reducing power by FRAP method,Other,21955455.0,
1094,690600,1,3,,103166767,14985,Active,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity,Other,21955455.0,
1095,690601,1,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as rate constant for DPPH free radical scavenging activity by stopped flow spectroscopy,Other,21955455.0,
1096,690612,1,2,,103166767,14985,Active,,,,,Antioxidant activity assessed as ABTS+ free radical scavenging activity by TEAC assay,Other,21955455.0,
1097,690614,1,2,,103166767,14985,Inactive,,,,,Antioxidant activity assessed as formation of DPPH breakdown product at 0.5 mM incubated for 20 mins by HPLC,Other,21955455.0,
1098,691690,2,3,,103166767,14985,Unspecified,,,59.0,IC50,Antioxidant activity of the compound assessed as DPPH radical scavenging activity,Confirmatory,22995623.0,
1099,691692,1,3,,103166767,14985,Active,,,,,Antioxidant activity of the compound assessed as DPPH radical scavenging activity at 50 uM,Other,22995623.0,
1100,709671,1,2,,103166767,14985,Active,,,,,Antioxidant activity in Sprague-Dawley albino rat brain homogenate assessed as inhibition of hydroxyl radical dependent lipoperoxidation measuring malondialdehyde production at 100 uM after 30 mins by TBARS assay,Other,23134227.0,
1101,720504,1,1,,47193687,14985,Inactive,21359873.0,5347.0,,Potency,qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen,Confirmatory,,
1102,720508,1,1,,47193687,14985,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn7) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
1103,720509,1,1,,47193687,14985,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn6) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
1104,720511,1,1,,47193687,14985,Inactive,89348172.0,1080.0,,,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_SinglePoint_HTS_Activity,Screening,,
1105,720516,2,1,,144204114,14985,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1106,720516,2,1,,144206759,14985,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1107,720516,2,1,,144209279,14985,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1108,720532,1,1,,26754431,14985,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1109,720532,1,1,,29215205,14985,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1110,720532,1,1,,144204114,14985,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1111,720532,1,1,,144206759,14985,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1112,720533,1,1,,26754431,14985,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1113,720533,1,1,,29215205,14985,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1114,720533,1,1,,144204114,14985,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1115,720533,1,1,,144206759,14985,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1116,720542,1,2,,47193687,14985,Inactive,23496270.0,810891.0,,Potency,qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen,Confirmatory,,
1117,720543,1,1,,47193687,14985,Inactive,326937491.0,105501.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4).,Screening,,
1118,720551,1,2,,47193687,14985,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS,Confirmatory,,
1119,720552,2,1,,144204114,14985,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1120,720552,2,1,,144206759,14985,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1121,720552,2,1,,144209279,14985,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1122,720553,1,2,,47193687,14985,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS,Confirmatory,,
1123,720579,2,1,,47193687,14985,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1124,720580,1,1,,47193687,14985,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1125,720582,1,1,,47193687,14985,Inactive,2393947.0,102.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM10.,Screening,,
1126,720596,1,1,,47193687,14985,Inactive,4506113.0,5621.0,,,TRFRET-based cell-based primary high throughput screening assay to identify inhibitors of cell surface Prion Protein (PRPC),Screening,,
1127,720634,2,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1128,720634,2,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1129,720634,2,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1130,720635,2,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1131,720635,2,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1132,720635,2,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1133,720637,2,1,,144204114,14985,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1134,720637,2,1,,144206759,14985,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1135,720637,2,1,,144209279,14985,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1136,720648,1,1,,47193687,14985,Inactive,73747889.0,6868.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM17.,Screening,,
1137,720674,2,2,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1138,720674,2,2,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1139,720674,2,2,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1140,720675,2,2,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1141,720675,2,2,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1142,720675,2,2,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1143,720678,2,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1144,720678,2,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1145,720678,2,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1146,720679,2,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1147,720679,2,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1148,720679,2,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1149,720680,2,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1150,720680,2,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1151,720680,2,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1152,720681,2,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1153,720681,2,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1154,720681,2,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1155,720682,2,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1156,720682,2,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1157,720682,2,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1158,720683,2,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1159,720683,2,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1160,720683,2,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1161,720684,2,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1162,720684,2,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1163,720684,2,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1164,720685,2,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1165,720685,2,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1166,720685,2,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1167,720686,2,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1168,720686,2,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1169,720686,2,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1170,720687,2,2,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1171,720687,2,2,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1172,720687,2,2,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1173,720691,4,1,,144204114,14985,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1174,720691,4,1,,144206759,14985,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1175,720691,4,1,,144209279,14985,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1176,720692,3,1,,144204114,14985,Inconclusive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1177,720692,3,1,,144206759,14985,Inconclusive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1178,720692,3,1,,144209279,14985,Inconclusive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1179,720693,3,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1180,720693,3,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1181,720693,3,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1182,720700,1,4,,47193687,14985,Inactive,223459640.0,5335.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-gamma1).,Screening,,
1183,720702,1,1,,47193687,14985,Inactive,23510348.0,51567.0,,,Epi Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2),Screening,,
1184,720704,1,4,,47193687,14985,Inactive,148745659.0,5331.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-beta3).,Screening,,
1185,720707,1,2,,47193687,14985,Inactive,317373593.0,10411.0,5.0119,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
1186,720708,1,2,,47193687,14985,Inactive,32171491.0,11069.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen,Confirmatory,,
1187,720709,1,2,,47193687,14985,Inactive,317373593.0,10411.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
1188,720711,1,2,,47193687,14985,Inactive,32171491.0,11069.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen,Confirmatory,,
1189,720719,2,1,,144204114,14985,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1190,720719,2,1,,144206759,14985,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1191,720719,2,1,,144209279,14985,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1192,720725,2,1,,144204114,14985,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1193,720725,2,1,,144206759,14985,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1194,720725,2,1,,144209279,14985,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1195,721640,1,3,,103166767,14985,Active,,,,,Antioxidant activity assessed as trolox equivalent of DPPH radical scavenging activity by spectroscopic analysis,Other,23314047.0,
1196,733735,1,3,,103166767,14985,Unspecified,,,,,Antioxidant activity in rat erythrocytes assessed as inhibition of phenyl hydrazine-induced haemolysis after 1 hr,Other,23395966.0,
1197,735840,2,2,,103166767,14985,Active,,,27.21,ED50,Antioxidant activity assessed as DPPH radical scavenging activity by ELISA,Confirmatory,23540981.0,
1198,736486,1,2,,103166767,14985,Active,,,26.8,IC50,Antioxidant activity assessed as inhibition of ABTS radical formation for 15 mins by spectrophotometric analysis,Confirmatory,23357310.0,
1199,736487,1,3,,103166767,14985,Unspecified,,,,IC50,Antioxidant activity assessed as inhibition of DPPH radical formation measured every min for 45 mins by spectrophotometric analysis,Confirmatory,23357310.0,
1200,743012,3,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1201,743012,3,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1202,743012,3,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1203,743014,3,1,,144204114,14985,Inconclusive,,,16.7855,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1204,743014,3,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1205,743014,3,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1206,743015,3,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1207,743015,3,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1208,743015,3,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1209,743033,3,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1210,743033,3,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1211,743033,3,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1212,743035,2,1,,144204114,14985,Inconclusive,124375976.0,367.0,0.4772,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1213,743035,2,1,,144206759,14985,Inconclusive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1214,743035,2,1,,144209279,14985,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1215,743036,2,1,,144204114,14985,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1216,743036,2,1,,144206759,14985,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1217,743036,2,1,,144209279,14985,Inconclusive,124375976.0,367.0,1.1051,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1218,743040,3,1,,144204114,14985,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1219,743040,3,1,,144206759,14985,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1220,743040,3,1,,144209279,14985,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1221,743041,3,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1222,743041,3,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1223,743041,3,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1224,743042,3,1,,144204114,14985,Inactive,124375976.0,367.0,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1225,743042,3,1,,144206759,14985,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1226,743042,3,1,,144209279,14985,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1227,743053,2,1,,144204114,14985,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1228,743053,2,1,,144206759,14985,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1229,743053,2,1,,144209279,14985,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1230,743054,2,1,,144204114,14985,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1231,743054,2,1,,144206759,14985,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1232,743054,2,1,,144209279,14985,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1233,743063,2,1,,144204114,14985,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1234,743063,2,1,,144206759,14985,Inconclusive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1235,743063,2,1,,144209279,14985,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1236,743064,3,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1237,743064,3,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1238,743064,3,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1239,743065,3,1,,144204114,14985,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1240,743065,3,1,,144206759,14985,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1241,743065,3,1,,144209279,14985,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1242,743066,3,1,,144204114,14985,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1243,743066,3,1,,144206759,14985,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1244,743066,3,1,,144209279,14985,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1245,743067,2,1,,144204114,14985,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1246,743067,2,1,,144206759,14985,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1247,743067,2,1,,144209279,14985,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1248,743069,2,1,,144204114,14985,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1249,743069,2,1,,144206759,14985,Inconclusive,348019627.0,2099.0,1.1986,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1250,743069,2,1,,144209279,14985,Inactive,348019627.0,2099.0,8.7779,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1251,743074,2,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1252,743074,2,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1253,743074,2,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1254,743075,2,1,,144204114,14985,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1255,743075,2,1,,144206759,14985,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1256,743075,2,1,,144209279,14985,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1257,743077,2,1,,144204114,14985,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1258,743077,2,1,,144206759,14985,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1259,743077,2,1,,144209279,14985,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1260,743078,2,1,,144204114,14985,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1261,743078,2,1,,144206759,14985,Inconclusive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1262,743078,2,1,,144209279,14985,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1263,743079,3,1,,144204114,14985,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1264,743079,3,1,,144206759,14985,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1265,743079,3,1,,144209279,14985,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1266,743080,3,1,,144204114,14985,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1267,743080,3,1,,144206759,14985,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1268,743080,3,1,,144209279,14985,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1269,743081,3,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1270,743081,3,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1271,743081,3,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1272,743083,3,1,,144204114,14985,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1273,743083,3,1,,144206759,14985,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1274,743083,3,1,,144209279,14985,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1275,743084,3,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1276,743084,3,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1277,743084,3,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1278,743085,3,1,,144204114,14985,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1279,743085,3,1,,144206759,14985,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1280,743085,3,1,,144209279,14985,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1281,743086,3,1,,144204114,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1282,743086,3,1,,144206759,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1283,743086,3,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1284,743091,2,1,,144204114,14985,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1285,743091,2,1,,144206759,14985,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1286,743091,2,1,,144209279,14985,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1287,743094,3,1,,144204114,14985,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1288,743094,3,1,,144206759,14985,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1289,743094,3,1,,144209279,14985,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1290,743122,2,1,,144204114,14985,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1291,743122,2,1,,144206759,14985,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1292,743122,2,1,,144209279,14985,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1293,743126,1,1,,47193687,14985,Inactive,119580345.0,50487.0,,,QFRET-based biochemical high throughput primary assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2),Screening,,
1294,743139,2,1,,144204114,14985,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1295,743139,2,1,,144206759,14985,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1296,743139,2,1,,144209279,14985,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1297,743140,2,1,,144204114,14985,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1298,743140,2,1,,144206759,14985,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1299,743140,2,1,,144209279,14985,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1300,743191,3,1,,144209279,14985,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1301,743194,3,1,,144209279,14985,Inconclusive,,,9.849,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1302,743199,2,1,,144209279,14985,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1303,743202,4,1,,144209279,14985,Inconclusive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1304,743203,3,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1305,743209,3,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1306,743210,4,1,,144209279,14985,Inconclusive,4504517.0,3315.0,4.3994,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1307,743211,3,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1308,743212,3,1,,144209279,14985,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1309,743213,3,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1310,743215,3,1,,144209279,14985,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1311,743217,3,1,,144209279,14985,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1312,743218,3,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1313,743219,3,1,,144209279,14985,Inactive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1314,743220,3,1,,144209279,14985,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1315,743221,3,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1316,743222,3,1,,144209279,14985,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1317,743223,3,1,,144209279,14985,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1318,743224,3,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1319,743225,3,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1320,743226,2,1,,144209279,14985,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1321,743227,2,1,,144209279,14985,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1322,743228,3,1,,144209279,14985,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1323,743238,1,1,,47193687,14985,Inactive,,,,,High Content Cell-Based Imaging Primary HTS to Identify Small Molecules Involved in X-Chromosome Reactivation and Reprogramming Measured in Cell-Based System Using Imaging - 7015-01_Activator_SinglePoint_HTS_Activity_Set2,Screening,,
1324,743239,2,1,,144209279,14985,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1325,743240,2,1,,144209279,14985,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1326,743241,2,1,,144209279,14985,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1327,743242,2,1,,144209279,14985,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1328,743244,1,1,,144204114,14985,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
1329,743244,1,1,,144206759,14985,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
1330,743247,1,2,,47193687,14985,Inactive,,,,,Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1331,743255,1,1,,47193687,14985,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Primary Screen,Confirmatory,,
1332,743266,1,2,,47193687,14985,Inactive,296080761.0,5745.0,,Potency,qHTS of PTHR Inhibitors: Primary Screen,Confirmatory,,
1333,743269,1,1,,47193687,14985,Inactive,2853980.0,,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
1334,743269,1,1,,47193687,14985,Inactive,6708281.0,11168.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
1335,743279,1,2,,47193687,14985,Inactive,10835145.0,3553.0,,,qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary Screen,Screening,,
1336,743397,1,1,,47193687,14985,Inactive,,,,,HTS for Inhibition of CaV1.3 ICDI/IQ interaction using a live-cell FRET assay Measured in Cell-Based System Using Plate Reader - 7081-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1337,743398,1,1,,47193687,14985,Inactive,,,,,Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity,Screening,,
1338,751084,1,3,,103166767,14985,Unspecified,,,54.2,IC50,Antioxidant activity in rat liver microsome assessed as inhibition of Fe2+-cysteine-induced lipid peroxidation after 15 mins,Confirmatory,23734721.0,
1339,762723,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity against ferric chloride-induced lipid peroxidation using egg lecithin at 5 ug/ml after 1 hr,Other,23850201.0,
1340,762725,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity against ferric chloride-induced lipid peroxidation using egg lecithin at 2.5 ug/ml after 1 hr,Other,23850201.0,
1341,762726,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity against ferric chloride-induced lipid peroxidation using egg lecithin at 1 ug/ml after 1 hr,Other,23850201.0,
1342,762727,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity against ferric chloride-induced lipid peroxidation using egg lecithin at 0.75 ug/ml after 1 hr,Other,23850201.0,
1343,762728,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity against ferric chloride-induced lipid peroxidation using egg lecithin at 0.5 ug/ml after 1 hr,Other,23850201.0,
1344,762729,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity against ferric chloride-induced lipid peroxidation using egg lecithin at 0.25 ug/ml after 1 hr,Other,23850201.0,
1345,762730,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity against ferric chloride-induced lipid peroxidation using egg lecithin at 0.1 ug/ml after 1 hr,Other,23850201.0,
1346,762731,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity against ferric chloride-induced lipid peroxidation using egg lecithin at 0.05 ug/ml after 1 hr,Other,23850201.0,
1347,762733,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity against ferric chloride-induced lipid peroxidation using egg lecithin at 0.01 ug/ml after 1 hr,Other,23850201.0,
1348,762734,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity against ferric chloride-induced lipid peroxidation using egg lecithin at 50 ug/ml after 1 hr,Other,23850201.0,
1349,762735,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity against ferric chloride-induced lipid peroxidation using egg lecithin at 100 ug/ml after 1 hr,Other,23850201.0,
1350,762736,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity against ferric chloride-induced lipid peroxidation using egg lecithin at 10 ug/ml after 1 hr,Other,23850201.0,
1351,762737,1,1,,103166767,14985,Inconclusive,,,,,Antioxidant activity assessed as reducing power of ferric ion at 50 ug/ml after 20 mins,Other,23850201.0,
1352,762738,1,1,,103166767,14985,Inconclusive,,,,,Antioxidant activity assessed as reducing power of ferric ion at 100 ug/ml after 20 mins,Other,23850201.0,
1353,762739,1,1,,103166767,14985,Inconclusive,,,,,Antioxidant activity assessed as reducing power of ferric ion at 10 ug/ml after 20 mins,Other,23850201.0,
1354,762740,1,2,,103166767,14985,Inconclusive,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 50 ug/ml after 20 mins,Other,23850201.0,
1355,762741,1,2,,103166767,14985,Inconclusive,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 100 ug/ml after 20 mins,Other,23850201.0,
1356,762742,1,2,,103166767,14985,Inconclusive,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 10 ug/ml after 20 mins,Other,23850201.0,
1357,770338,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition of microsomal lipid peroxidation at 200 ug/mL by spectrophotometric analysis relative to control,Other,23954239.0,
1358,770339,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition of hydroxyl radical generation at 200 ug/mL after 90 mins by spectrophotometric analysis relative to control,Other,23954239.0,
1359,771137,1,2,,103166767,14985,Unspecified,,,132.81,EC50,Antioxidant activity assessed as DPPH radical scavenging activity incubated for 20 mins under dark condition by spectrophotometric analysis,Confirmatory,23978651.0,
1360,771138,1,2,,103166767,14985,Active,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 5 to 500 uM incubated for 20 mins under dark condition by spectrophotometric analysis,Other,23978651.0,
1361,771143,1,1,,103166767,14985,Unspecified,,,944.62,EC50,Antioxidant activity assessed as reduction of K3FeCN6 by spectrophotometric analysis in presence of FeCl3,Confirmatory,23978651.0,
1362,771144,1,1,,103166767,14985,Active,,,,,Antioxidant activity assessed as reduction of K3FeCN6 at 1 to 500 uM by spectrophotometric analysis in presence of FeCl3,Other,23978651.0,
1363,772993,1,1,,103166767,14985,Active,,,,,Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity at pH 7.4 by spectrophotometry,Other,23994869.0,
1364,776227,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as reduction of microsomal lipid per-oxidation level by measuring formation of malondialdehyde at 200 ug/ml after 90 mins by spectrophotometric analysis relative to control,Other,24090915.0,
1365,1053197,1,1,,47193687,14985,Inactive,74734243.0,54414.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of sialic acid acetylesterase (SIAE),Screening,,
1366,1079931,1,1,,103166767,14985,Unspecified,,,,,"Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]",Other,15646539.0,
1367,1079932,1,1,,103166767,14985,Unspecified,,,,,"Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]",Other,15646539.0,
1368,1079933,1,1,,103166767,14985,Unspecified,,,,,"Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]",Other,15646539.0,
1369,1079934,1,1,,103166767,14985,Unspecified,,,,,"Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]",Other,15646539.0,
1370,1079935,1,1,,103166767,14985,Unspecified,,,,,"Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]",Other,15646539.0,
1371,1079936,1,1,,103166767,14985,Unspecified,,,,,"Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]",Other,15646539.0,
1372,1079937,1,1,,103166767,14985,Unspecified,,,,,"Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]",Other,15646539.0,
1373,1079938,1,1,,103166767,14985,Unspecified,,,,,"Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]",Other,15646539.0,
1374,1079939,1,1,,103166767,14985,Unspecified,,,,,"Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]",Other,15646539.0,
1375,1079940,1,1,,103166767,14985,Unspecified,,,,,"Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]",Other,15646539.0,
1376,1079941,1,1,,103166767,14985,Unspecified,,,,,"Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]",Other,15646539.0,
1377,1079942,1,1,,103166767,14985,Unspecified,,,,,"Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]",Other,15646539.0,
1378,1079943,1,1,,103166767,14985,Unspecified,,,,,"Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]",Other,15646539.0,
1379,1079944,1,1,,103166767,14985,Unspecified,,,,,"Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]",Other,15646539.0,
1380,1079945,1,1,,103166767,14985,Unspecified,,,,,Animal toxicity known. [column 'TOXIC' in source],Other,15646539.0,
1381,1079946,1,1,,103166767,14985,Unspecified,,,,,Presence of at least one case with successful reintroduction. [column 'REINT' in source],Other,15646539.0,
1382,1079947,1,1,,103166767,14985,Unspecified,,,,,Comments (NB not yet translated). [column 'COMMENTAIRES' in source],Other,15646539.0,
1383,1079948,1,1,,103166767,14985,Unspecified,,,,,"Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]",Other,15646539.0,
1384,1079949,1,1,,103166767,14985,Unspecified,,,,,Proposed mechanism(s) of liver damage. [column 'MEC' in source],Other,15646539.0,
1385,1087145,1,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 125 ug,Other,,
1386,1087146,1,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 100 ug,Other,,
1387,1087147,1,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 50 ug,Other,,
1388,1087148,1,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 75 ug,Other,,
1389,1087149,1,3,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 25 ug,Other,,
1390,1087151,1,2,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition of linoleic acid peroxidation at 100 ug by FTC method,Other,,
1391,1087152,1,2,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition of linoleic acid peroxidation at 125 ug by FTC method,Other,,
1392,1087153,1,2,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition of linoleic acid peroxidation at 75 ug by FTC method,Other,,
1393,1087154,1,2,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition of linoleic acid peroxidation at 50 ug by FTC method,Other,,
1394,1087155,1,2,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition of linoleic acid peroxidation at 25 ug by FTC method,Other,,
1395,1093497,1,2,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as superoxide radical scavenging activity at 10 '-3 M measured for 3 min by spectrophotometry relative to control,Other,,
1396,1093498,1,2,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as superoxide radical scavenging activity at 10 '-4 M measured for 3 min by spectrophotometry relative to control,Other,,
1397,1093499,1,3,,103166767,14985,Unspecified,,,,,Antioxidant activity in Rattus norvegicus (rat) liver homogenate assessed as inhibition of lipid peroxidation measuring TBARS production at 10 '-3 M after 1 hr by spectrophotometry relative to control,Other,,
1398,1093500,1,3,,103166767,14985,Unspecified,,,,,Antioxidant activity in Rattus norvegicus (rat) liver homogenate assessed as inhibition of lipid peroxidation measuring TBARS production at 10 '-4 M after 1 hr by spectrophotometry relative to control,Other,,
1399,1095419,1,3,,103166767,14985,Unspecified,,,,,Antioxidant activity in Rattus norvegicus (rat) liver microsomes assessed as inhibition of lipid peroxidation at 20 ug/ml after 90 min by thiobarbuteric acid method,Other,,
1400,1113642,1,2,,103166767,14985,Active,,,,,Antioxidant activity measured after 3 min by ferric thiocyanate method,Other,,
1401,1116455,1,2,,103166767,14985,Active,,,,,Antioxidant activity assessed as inhibition of linoleic acid peroxidation at 100 mg/l after 24 hr by spectrophotometric analysis,Other,,
1402,1116461,1,2,,103166767,14985,Active,,,,,Antioxidant activity assessed as reduction of Fe3+ to Fe2+ at 20 to 140 ug/ml after 30 min by spectrophotometric analysis,Other,,
1403,1117322,1,1,,225144220,14985,Active,,,2.6147,IC50,RKO viability from Cell TiterGlo-IC50,Confirmatory,,
1404,1117323,1,1,,225144220,14985,Inactive,,,20.0,IC50,SNU-C1 viability from Cell TiterGlo-IC50,Confirmatory,,
1405,1117324,1,1,,225144220,14985,Inactive,,,10.0,IC50,VEGF stimulated ADSC/ECFC co-culture nuclear area decrease (viability)-IC50,Confirmatory,,
1406,1117326,1,1,,225144220,14985,Inactive,,,,,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-screen,Screening,,
1407,1117329,1,1,,225144220,14985,Inactive,,,,,insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen,Screening,,
1408,1117330,1,1,,225144220,14985,Inactive,,,20.0,IC50,HT-29 viability from Cell TiterGlo-IC50,Confirmatory,,
1409,1117332,1,1,,225144220,14985,Inactive,,,20.0,IC50,HCT116 viability from Cell TiterGlo-IC50,Confirmatory,,
1410,1117334,1,1,,225144220,14985,Inactive,,,20.0,IC50,Colo320 viability from Cell TiterGlo-IC50,Confirmatory,,
1411,1117337,1,1,,225144220,14985,Inactive,,,10.0,IC50,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50,Confirmatory,,
1412,1117338,1,1,,225144220,14985,Inactive,,,20.0,IC50,SW480 viability from Cell TiterGlo-IC50,Confirmatory,,
1413,1117341,1,1,,225144220,14985,Inactive,,,,,GLP1 secretion from NCI-H716 cells-screen,Screening,,
1414,1117352,1,1,,225144220,14985,Inactive,,,20.0,IC50,DLD-1 viability from Cell TiterGlo-IC50,Confirmatory,,
1415,1143924,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as suppression of microsomal lipid peroxidation measured as MDA formation at 200 ug/ml after 90 mins by spectrophotometry relative to control,Other,24871900.0,
1416,1155643,1,2,,103166767,14985,Active,,,26.94,IC50,Antioxidant activity assessed as 150 uM DPPH free radical scavenging activity under dark condition after 30 mins by microplate reader analysis,Confirmatory,24927000.0,
1417,1155644,1,2,,103166767,14985,Unspecified,,,62.09,IC50,Antioxidant activity assessed as 300 uM DPPH free radical scavenging activity under dark condition after 30 mins by microplate reader analysis,Confirmatory,24927000.0,
1418,1159509,1,1,,144209279,14985,Inconclusive,119626539.0,4790.0,31.1452,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
1419,1159515,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
1420,1159516,1,1,,144209279,14985,Inconclusive,119611100.0,22926.0,31.1452,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
1421,1159517,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
1422,1159518,1,1,,144209279,14985,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
1423,1159519,1,1,,144209279,14985,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
1424,1159520,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1425,1159521,1,1,,144209279,14985,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1426,1159523,1,1,,144209279,14985,Inconclusive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
1427,1159524,1,1,,47193687,14985,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1428,1159525,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
1429,1159526,1,1,,144209279,14985,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
1430,1159527,1,1,,144209279,14985,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
1431,1159528,1,1,,144209279,14985,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
1432,1159529,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
1433,1159531,1,1,,144209279,14985,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
1434,1159550,3,1,,252402403,14985,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
1435,1159551,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
1436,1159552,1,1,,144209279,14985,Inconclusive,325495463.0,5914.0,24.5346,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1437,1159553,2,1,,144209279,14985,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1438,1159555,1,1,,144209279,14985,Inconclusive,325495463.0,5914.0,61.6282,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
1439,1159606,1,1,,47193687,14985,Inactive,,,,,"uHTS identification of small molecule inhibitors of TWEAK-Fn14 interactions, using a cell-based reporter assay",Other,,
1440,1159607,2,1,,312596619,14985,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
1441,1159620,1,1,,103166767,14985,Active,,,,,Summary of drug indications.,Other,,
1442,1168138,1,1,,103166767,14985,Active,,,5.63,IC50,Antioxidant activity assessed as inhibition of lipid peroxidation after 1 hr by TBARS assay,Confirmatory,25299680.0,
1443,1168139,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as inhibition of lipid peroxidation at 100 uM after 1 hr by TBARS assay,Other,25299680.0,
1444,1172929,1,1,,103166767,14985,Active,,,,,Cytoprotective effect against H2O2-induced cell death in rat PC12 cells at 20 uM incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs by MTT assay,Other,25453793.0,
1445,1172934,1,1,,103166767,14985,Unspecified,,,,,Inhibition of H2O2-induced NO production in rat PC12 cells at 20 uM incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs relative to control,Other,25453793.0,
1446,1172936,1,1,,103166767,14985,Active,,,,,Inhibition of H2O2-induced LDH release in rat PC12 cells at 20 uM incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs relative to control,Other,25453793.0,
1447,1172940,1,1,,103166767,14985,Unspecified,,,,,Inhibition of intracellular ROS generation in rat PC12 cells at 20 uM incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs by fluorescence assay relative to control,Other,25453793.0,
1448,1179728,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as reduction in mouse CRL2181 cells-mediated human LDL oxidation by measuring TBARS level at 10 uM after 18 hrs,Other,24924425.0,
1449,1179729,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as reduction in mouse CRL2181 cells-mediated human LDL oxidation by measuring TBARS level at 1 uM after 18 hrs,Other,24924425.0,
1450,1179730,1,1,,103166767,14985,Unspecified,,,,,Cytoprotection in mouse CRL2181 cells assessed as reduction in UV-oxidized LDL-induced cytotoxicity by measuring cell viability at 10 uM after 24 hrs by MTT assay relative to untreated control,Other,24924425.0,
1451,1179731,1,1,,103166767,14985,Inconclusive,,,,,Cytoprotection in mouse CRL2181 cells assessed as reduction in UV-oxidized LDL-induced cytotoxicity by measuring cell viability at 1 uM after 24 hrs by MTT assay relative to untreated control,Other,24924425.0,
1452,1179743,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity in HUVEC assessed as suppression of ROS production by measuring fluorescent intensity index at 100 uM pre-incubated for 24 hrs before H2O2 stimulation for 2 hrs by DCF dye based fluorimetric assay,Other,24928401.0,
1453,1179804,1,2,,103166767,14985,Active,,,15.4,IC50,Antioxidant activity assessed as DPPH radical scavenging capacity after 30 mins by UV spectrophotometry,Confirmatory,24928405.0,
1454,1179805,1,1,,103166767,14985,Unspecified,,,211.1,IC50,Antioxidant activity assessed as ABTS+ radical scavenging capacity after 16 hrs by UV spectrophotometry,Confirmatory,24928405.0,
1455,1179806,1,1,,103166767,14985,Active,,,,,Antioxidant activity assessed as reduction of Cu2+ to Cu+ after 3 mins by PAO-SO method,Other,24928405.0,
1456,1179807,1,1,,103166767,14985,Unspecified,,,,,Cytotoxicity against human HCT116 cells assessed as reduction cell viability at 100 uM after 48 hrs by MTT assay,Other,24928405.0,
1457,1182518,1,1,,103166767,14985,Active,,,,,Radioprotective activity against gamma-irradiated human MOLT4 cells preincubated for 1 hr at <50 uM before gamma-irradiation measured after 18 hrs by erythrosine B dye-exclusion test,Other,25002230.0,
1458,1202555,1,1,,103166767,14985,Active,,,14.84,IC50,Antioxidant activity assessed as inhibition of ABTS free radical scavenging activity after 10 mins by spectrophotometry relative to control,Confirmatory,25899334.0,
1459,1224834,3,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1460,1224835,1,1,,144209279,14985,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1461,1224836,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1462,1224837,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1463,1224838,1,1,,144209279,14985,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1464,1224839,1,1,,144209279,14985,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1465,1224840,3,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1466,1224841,3,1,,144209279,14985,Inconclusive,325495545.0,2101.0,3.8885,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1467,1224842,3,1,,144209279,14985,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1468,1224843,1,1,,144209279,14985,Inconclusive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1469,1224844,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1470,1224845,1,1,,144209279,14985,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1471,1224846,1,1,,144209279,14985,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1472,1224847,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1473,1224848,3,1,,144209279,14985,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1474,1224849,3,1,,144209279,14985,Inactive,325495545.0,2101.0,19.4886,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1475,1224865,1,2,,47193687,14985,Inactive,578162.0,,,,Identify inhibitors of HNF4 alpha protein binding to DNA,Screening,,
1476,1224867,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1477,1224868,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1478,1224869,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1479,1224870,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1480,1224871,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1481,1224872,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1482,1224873,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1483,1224874,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1484,1224875,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1485,1224876,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1486,1224877,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1487,1224878,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1488,1224879,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1489,1224880,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1490,1224881,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1491,1224882,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1492,1224883,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1493,1224884,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1494,1224885,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1495,1224886,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1496,1224887,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1497,1224888,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1498,1224889,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1499,1224890,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1500,1224892,1,1,,144209279,14985,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1501,1224893,1,1,,144209279,14985,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1502,1224894,1,1,,144209279,14985,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1503,1224895,1,1,,144209279,14985,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1504,1224896,1,1,,144209279,14985,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1505,1234555,1,1,,103166767,14985,Active,,,0.8,IC50,Antioxidant activity in soybean large unilamellar vesicles assessed as inhibition of AAPH-induced lipid peroxidation compound added prior to AAPH induction measured after 90 mins by UV-visible absorption spectrometric analysis,Confirmatory,26068016.0,
1506,1256761,1,1,,103166767,14985,Inactive,,,,,Inhibition of Mycobacterium tuberculosis MTCC 300 DAH7PS expressed in Escherichia coli BL21 (DE3) using 25 to 125 uM PEP/100 uM E4P as substrate up to 50 nM by spectrophotometric analysis,Other,26491981.0,
1507,1256762,1,1,,103166767,14985,Unspecified,,,,,Inhibition of Mycobacterium tuberculosis MTCC 300 DAH7PS expressed in Escherichia coli BL21 (DE3) using 25 to 125 uM PEP/100 uM E4P as substrate at 10 uM by spectrophotometric analysis relative to control,Other,26491981.0,
1508,1256763,1,1,,103166767,14985,Unspecified,,,,IC50,Inhibition of Mycobacterium tuberculosis MTCC 300 DAH7PS expressed in Escherichia coli BL21 (DE3) using 25 to 125 uM PEP/100 uM E4P as substrate by spectrophotometric analysis,Confirmatory,26491981.0,
1509,1257005,1,1,,103166767,14985,Unspecified,,,,,Antioxidant activity assessed as DPPH scavenging activity at 10 to 60 ug/ml after 30 mins,Other,26514744.0,
1510,1259241,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1511,1259242,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1512,1259243,1,1,,144209279,14985,Inactive,124375976.0,367.0,6.1628,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1513,1259244,1,1,,144209279,14985,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1514,1259247,1,1,,144209279,14985,Inconclusive,124375976.0,367.0,11.6086,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1515,1259248,1,1,,144209279,14985,Inconclusive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1516,1259251,1,1,,47193687,14985,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify inhibitors of Unc-51 Like Autophagy Activating Kinase 1 (ULK1).,Screening,,
1517,1259313,1,1,,47193687,14985,Inactive,,,,,uHTS identification of small molecule modulators of NR3A,Screening,,
1518,1259318,1,1,,47193687,14985,Inactive,,,,,uHTS identification of small molecule modulators of Rev-erb Alpha.,Screening,,
1519,1259344,1,1,,144204114,14985,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
1520,1259344,1,1,,144206759,14985,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
1521,1259356,1,1,,144204114,14985,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
1522,1259364,1,1,,144209279,14985,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1523,1259365,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1524,1259366,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1525,1259367,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1526,1259368,1,1,,144209279,14985,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1527,1259369,1,1,,144209279,14985,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1528,1259377,1,1,,144209279,14985,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1529,1259378,1,1,,144209279,14985,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1530,1259379,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1531,1259380,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1532,1259381,1,1,,144209279,14985,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1533,1259382,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1534,1259383,1,1,,144209279,14985,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1535,1259384,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1536,1259385,1,1,,144209279,14985,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1537,1259386,1,1,,144209279,14985,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1538,1259387,1,1,,144209279,14985,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1539,1259388,1,1,,144209279,14985,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1540,1259390,1,1,,144209279,14985,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1541,1259391,1,1,,144209279,14985,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1542,1259392,1,1,,144209279,14985,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1543,1259393,1,1,,144209279,14985,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1544,1259394,1,1,,144209279,14985,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1545,1259395,1,1,,144209279,14985,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1546,1259396,1,1,,144209279,14985,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1547,1259401,1,1,,144209279,14985,Inconclusive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1548,1259402,1,1,,144209279,14985,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1549,1259403,1,1,,144209279,14985,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1550,1259404,1,1,,144209279,14985,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1551,1259407,1,1,,363901538,14985,Inactive,,,,,CCRIS mutagenicity studies,Other,,
1552,1259408,1,1,,363896051,14985,Unspecified,,,,,GENE-TOX mutagenicity studies,Other,,
1553,1259409,1,1,,363901538,14985,Unspecified,,,,,CCRIS tumor inhibitor studies,Other,,
1554,1259415,1,1,,47193687,14985,Inactive,,,,,qHTS Assay for inhibitors of the human cytomegalovirus (HCMV),Screening,,
1555,1259423,1,2,,354924738,14985,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
